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Abstract
It is well known that the part of scientific findings that are published in journals are a biased
sample of the overall amount of research that is done. Often, editors aim to publish new and
influential results that will be distributed further by other researchers and heighten their journal
impact factor. The downside of it is that some of these results might only be positive by chance,
or because of poor study design. When decision makers use this information to take actions,
they are likely to be mislead.
In this study, the prevalence and impact of publication bias is assessed in a large scale analysis.
The data stems from the Cochrane Library of Systematic Reviews, the biggest collection of
clinical trial and public health intervention data. Meta-Analyses of Cochrane are scrutinized for
small-study effects and excess significance, both signs of publication bias. We also adjust the
treatment effects from the meta-analysis for publication bias and compare the newly obtained
effects with unadjusted treatment effects. In an exploratory analysis, we find that around 20%
of meta-analyses are subject to publication bias, and that the evidence for treatment efficacy
decreases after adjustment. Publication bias thus remains a threat to the validity of findings in
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Studies get more attention and are more likely to be published, read and cited if they contain
significant effects. Studies with no evidence for an effect are less likely to get published. This
generates a bias called “publication bias”, a distorted view of the evidence for an effect. Publi-
cation bias has been identified as one of the major concerns in irreproducible research (Bishop,
2019). The issue has been discussed in clinical science by many researchers (Dickersin et al.,
1987, Sterne et al., 2001, Dwan et al., 2013). Consensus is that publication bias exists in clinical
science.
In medical research, clinical trials study the efficacy of therapies and drugs. The gold standard
in such intervention studies are randomized controlled trials (RCTs). Results from RCTs influ-
ence the treatment of patients in daily clinical practice. The results from multiple intervention
studies can be summarized in a meta-analysis to estimate an overall treatment effect (across all
studies) (Cochran, 1954). However, publication bias can bias the overall effect estimates from
meta-analyses and eventually lead to ineffective treatments that could lead to patient harm,
distortion and financial expenses.
There is extensive literature on publication bias in meta-analyses, e. g . (Jones et al., 2013, Turner
et al., 2008, Egger et al., 2003, McAuley et al., 2000). The authors agree on that the exclusion of
unpublished results in meta-analyses can lead to overestimation of treatment effects (e. g . Egger
et al., 1997). Although there are policies that make it mandatory to make all study results pub-
licly accessible (US Public Law, 2007), it is not clear if the situation has improved yet. There are
also notable efforts from both journals (Abbasi, 2004) and researchers (DORA: San Francisco
declaration of research assessment).
There are multiple ways to assess the amount of publication bias. For instance, it is possible to
follow studies and assess if they are getting published depending on their findings (Dwan et al.,
2013, Decullier et al., 2005, Lee et al., 2008). One often finds that positive findings (i. e. large
effects) are reported and published more often (see also an example in the social sciences: Franco
et al. (2014)). Another way is to compare results in study registries with results published in
journals (e. g . Jones et al., 2013). Again one finds systematic differences between published and
unpublished results.
A third way is to assess the so-called small study effect in a meta-analysis, that is, smaller studies
sometimes showing different, often larger treatment effects than large ones. The rationale is that
studies with larger standard errors have to have larger effects in order to be significant. The esti-
mation of small study effects is an efficient way to investigate publication bias in a large number
of meta-analyses. Although there are other reasons for small study effects as well, evidence for
small study effects can oftentimes be interpreted as evidence for publication bias (Egger et al.,
1997), as it is the most likely cause.
A funnel plot (Egger and Smith, 1995) allows visual inspection of small study effects by plotting
the effects against their standard error. For illustration purposes, one meta-analysis with large
funnel plot asymmetry and one with no asymmetry is shown in Figure 1.1. The purpose of
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Figure 1.1: Funnel plots of two meta-analyses: On the left, the improvement in de-
pression syndromes after application of tricyclic antidepressants is compared to placebo.
The meta-analysis on the right measures the occurrence of intracranial haemoerrhage
by CT after application of any anti-thrombolytic agent. All studies are RCT’s.
a funnel plot is to visualize if there are missing study results on one lower side of the funnel
plot. By means of simple linear regression, one can investigate how much evidence there is for
asymmetry.
We see that while the studies in the meta-analysis on the right rather accumulate on the
right side, they seem to be more evenly distributed in the right triangle. From this, we would
ultimately conclude that some sort of bias or heterogeneity is distorting the estimate of the over-
all treatment effect.
The Cochrane Organisation has specialized on systematic reviews of healthcare interventions.
Researchers that write a systematic review collect data across studies, review them and try to
provide up-to-date information about specific treatment efficacy (Higgins JPT, 2011). By sys-
tematic literature review, they try to circumvent the issue of publication bias. Earlier research
however suggests that the efforts are only partially successful, and that there still is publica-
tion bias within the reviews (Egger et al., 1997, Ioannidis and Trikalinos, 2007a, Kicinski et al.,
2015, van Aert et al., 2019). In these publications, Cochrane systematic reviews is analysed with
methods to detect publication bias, for example small study effect tests or Bayesian hierarchical
selection models (Kicinski et al., 2015). They all find moderate to large evidence for publication
bias in the database.
1.1 Aim of the Study
None of the research so far has estimated the amount and impact of publication bias on meta-
analytical findings thoroughly and with the most suitable methods. Also, the results are ironically
often presented in the form of dichotomous hypothesis tests, a practice that is partly responsible
for publication bias.
The aim of this thesis was to use prevailed methods to detect publication bias, and make use of
the full amount of data that the Cochrane Organisation provides. The research questions are: Are
effects in meta-analyses larger if their standard errors are small, and are there more significant
effects than expected? How can this affect the combined treatment effects as commonly obtained
by meta-analysis? To answer these questions, methods to detect and adjust for publication bias
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in meta-analysis are applied on the data.
At the end, we will not only give an estimate of publication bias in the Cochrane Library but
also show to what extent treatment effects are overestimated. The analyses are exploratory, but
may generate new hypotheses and stimulate future directions for confirmatory research.
6 CHAPTER 1. INTRODUCTION
Chapter 2
Methods
2.1 Introduction and Notation
The interventions are restricted to comparisons of two treatment groups by some measure of
melioration or worsening of health. The difference in this measure between the groups is referred
to as the treatment effect. Where it is not particularly mentioned, the term treatment effect
refers to any effect measure such as log risk ratio, log hazard ratio, log rate ratio, Cohen’s d or
standardized mean difference, Fisher’s z transformed score.
Let us consider a meta-analysis with n study treatment effects (n > 1, but typically small). A
study is indexed by i, and it’s treatment effect by θi. The observed treatment effect is θ̂i. The
pooled treatment effect of a meta-analysis will be denoted as θM , and consequently, the observed
pooled treatment effect as θ̂M . Furthermore, each treatment effect is typically measured with
some standard error sei and an estimate of sei is denoted as ŝei. Theˆsign thus indicates if it is
an estimate.
For continuous outcomes, let mt be the mean of the treatment group, mc the mean of the control
group, and equivalently sdt and sdc the corresponding standard deviations. In the case of binary
outcomes, let et be the count of events in the treatment arm ec the events in the control group.
nt and nc are the total number of participants in the groups (c for control and t for treatment).
2.2 Effect Measures and p-values
2.2.1 Continuous Outcomes
For given (mt,mc), (sdt, sdc) and (nt, nc), one can compute mean difference θ as well as a stan-
dardized mean difference (also known as Cohen’s d) and the standard error thereof.
θ = mt −mc sdθ =
√
sd2t /nt + sd
2
c/nc. (2.1)






(nt − 1)sd2t + (nc − 1)sd2c
nt + nc − 2
. (2.2)
Both estimators take into account that the two groups might have unequal variances.
A p -value to test the null hypothesis that the mean between group is equal is commonly obtained
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and the p -value can be obtained with the cumulative Student’s t-distribution F with nt +nc− 2
degrees of freedom:
p = 2(1− F (|t|)).
2.2.2 Binary Outcomes
Two commonly used effect measures for binary outcome data are risk ratios and odds ratios
between treatment and control groups. The methods presented here can also be found, for
example, in (Borenstein et al., 2011, 34). Let θ be the natural logarithm of the odds ratio. θ̂
and its variance ŝe2 can be obtained by computing
θ̂ = log
[
et · (nc − ec)
ec · (nt − et)
]
ŝe2 = 1/et + 1/(nt − et) + 1/ec + 1/(nc − ec).
Plugging in the observed counts will give the corresponding estimates. The logarithm of the







se2 = 1/et − 1/nt + 1/ec − 1/nc. (2.4)
Assuming binomial distribution of the events and using likelihood theory, one could show
that the estimators are maximum likelihood estimators and that one can use the asymptotic
normal distribution of the maximum likelihood estimator to calculate a p -value, e. g . (Held and
Sabanés Bové, 2014, 98). The approximation is only good if there are enough events and sample
size is large enough.
Thus, with Φ as the cumulative standard normal distribution, we get
p = 2 · (1− Φ(|θ̂/ŝe|)),
a p -value for the corresponding estimate, which summarizes the evidence against θ̂ being zero
(i. e. the true risk/odds ratio being 1).
Odds ratios can be transformed to std. mean differences, which will be described in Section 2.7.
2.2.3 Time-to-Event Outcomes
Usually, time-to-event data of two experimental groups can be compared by rate ratios. The
normal approximations of the maximum likelihood estimators also works here when using the
log rate ratio. Time-to-event data with censoring has to be analyzed by special means. One
frequently used method to take into account right-censoring is the Cox proportional hazards
regression model (Cox, 1972). Because the method itself is not applied in this thesis, but only
the resulting estimates of the parameters are used, the reader is referred to the extensive literature
covering this topic (e. g . Cox and Oakes, 1984).
The so-called hazard ratio estimated by Cox regression is the ratio of the instantaneous risk of
experiencing the event between two groups. Because it is a maximum likelihood estimator, one
can again use its Wald test statistic to test for equal hazards. Let θ̂ be an estimate of the log
hazard ratio and ŝe an estimate of the standard error of it. As before
p = 2 · (1− Φ(|θ̂/ŝe(θ̂)|)
will give a p -value for the evidence against the null hypothesis.
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2.3 Fixed and Random Effects Meta-Analysis
The fixed effects meta-analysis estimator of the pooled treatment effect is a mean of the single
treatment effect estimators, weighted by their standard errors (Rosenthal and Rubin, 1982). Let
wi = 1/ se
2
i be the weights, and θM be the pooled estimator and se
2
M its variance. Then the









This estimator minimizes the variance between the effects. An estimate θ̂M can be obtained
by plugging in the observed treatment effects and variances θ̂i and ŝe2i . The underlying idea is
that we assume θi ∼ N(θM , se2i ), θM being the true effect, all θi being distributed around an
equal mean.
The random effects model (Whitehead and Whitehead, 1991) assumes instead that
θi ∼ N(µi, se2i ) µi ∼ N(θM , τ2). (2.6)
Marginally, we have θi being distributed around a common mean θM with additional variance
τ2:
θi |µi ∼ N(θM , se2i +τ2).
τ2 is often referred to as a population variance or between-study variance, whereas se2i can
be interpreted as sampling error. The pooled treatment effect estimate θM of the random effects
model and its variance is obtained by replacing the weights wi in equation (2.5) with wi =
1/(se2i +τ
2).
The model is superior to the fixed effects model whenever the standard errors of the treatment
effects alone are unlikely to fully account for the entire variability observed between studies. The
method assigns larger weights to studies with larger standard errors.
The estimation of τ2 has been subject to some debate in the statistical literature. Oftentimes,
the method of moment estimator of DerSimonian and Laird (1986) is used. We use the measure





















The estimators have to be replaced by their estimates in order to get an estimate τ̂2.
The Paule-Mandel estimator (Paule and Mandel, 1982) is considered to have better properties
than the method of moments estimator (e. g . Veroniki et al., 2016). Since we defined wi =
1/(se2i +τ
2), it also holds that
wiVar(θi) = 1 Var(
√
wiθi) = 1.
For any wi, the variance can be estimated and equated to its expected value:
se2(wiθi) =
∑n
i=1wi(θi − θM )2
n− 1
∑n
i=1wi(θi − θM )2
n− 1
= 1. (2.9)
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After estimating θM with equation (2.5), the only problem remaining is to estimate τ2. τ̂2




wi(θi − θM )2 − (n− 1).
In view of equation (2.9), τ2 must be such that F (τ2) = 0. Then, we start with a arbitrary
τ2 and repeatedly add a term τ20 to update τ2 until F (τ2 + τ20 ) is close to zero (using τ2 + τ20 for
ŵi, θ̂M ). Using a truncated Taylor series expansion, one can obtain the partial derivative after
τ2, which is a reasonable choice for τ20 . Using τ2 + τ20 for ŵi, θ̂, we can update F (τ2) and check
convergence to zero.
The estimation of τ2 is accompanied by uncertainty. A common procedure is to test if it is there
is significant heterogeneity between the studies (Borenstein et al., 2011, p. 109). For this, Q has
to be computed as given in (2.7). It is assumed that Q follows a central Chi-squared distribution
with n− 1 degrees of freedom under the null hypothesis of equally distributed effect sizes. Thus,
the expected value of Q is n − 1, and the excess dispersion is Q − n + 1. The p -value against
the null hypothesis of equally distributed effect sizes is 1 − F (Q), using F as the cumulative
distribution function of the Chi-squared distribution with d.f. = n− 1.
τ2 is is directly linked to the variability in the data. The I2 statistic of excess/total dispersion can
be used alternatively to assess the extent of additional variance to the variances of the primary
study estimates. It is computed as
I2 = max
(
0, 1− n− 1
Q
)
The statistic takes values between zero and one, and is easily interpretable. 0 is equal to
0% excess dispersion and e. g . 0.5 equal to 50% additional between-study variance of the total
variance of the estimates.
Importantly, all proposed methods above assume normally distributed effect sizes and proper
estimates ŝe of the true standard error. This assumptions are not met for very small sample sizes
and very few event counts. Alternatively, the Mantel-Haenszel method for risk and odds ratios
(see e. g . Fleiss et al., 2013) could be used in the latter case.
2.4 Linear, Weighted and Linear Mixed Regression Models
First, the concept of simple linear regression is introduced (Fahrmeir et al., 2007). In short, the
model assumes a dependent variable y to be a linear function of another explanatory variable
x, with the residuals being distributed independently and identically and following a normal
distribution:
y = β0 + β1x+ ε, ε ∼ N(0, σ2). (2.10)
ε is the residual noise term that becomes necessary when n pairs (xi, yi) are given and there is
no exact solution. We look for the solution that minimizes the squared residuals, the least-squares





yi − β0 − β1xi
)
. (2.11)
Let X be a matrix with the explanatory variables x and y a corresponding vector for all y:

















Let β = (β0, β1)>. It can be shown that
β̂ = (X>X)−1X>y (2.12)
is an estimator of β that minimizes the squared residuals. Let ŷ = Xβ̂ and r̂ = ŷ − y. The




r>r̂ ŝ2β = σ̂
2(X>X)−1. (2.13)
If one plots the values of y and x, the estimate β̂0 is the intercept and β̂1 the slope of the
regression line. Furthermore, in the simple linear regression setting, β̂0 can also be obtained by:
β̂0 = ȳ − β̂1x̄.
x̄ and ȳ denoting the sample means of the corresponding values x1, .., xn and y1, ..., yn. Thus,
β̂0 is also called the global mean. To test whether there is evidence for the intercept β0 to be
unequal to some value βH0, a t-test can be used:
p = 2(1− F (|(β0 − βH0)/sβ0 |)),
where F is the cumulative t distribution with n − 2 degrees of freedom. The p -value will give
the evidence against the null hypothesis β0 = βH0.
The concept is extendable to weighted linear regression. Weighted linear regression may be used
if the residuals r have unequal variances, which is equivalent to ascribe different precision to the





wi(yi − β0 − β1xi)
)
with the positive weights wi penalizing large squared residuals for some i more if wi is larger.
Let W be a n × n matrix with Wii = wi, the weights on the diagonal and zeros on the off-
diagonals. The estimates in (2.12) and (2.13) can again be used ifX is exchanged withX? = WX
and y with y? = Wy.
The introduction of group-specific random effects allows to analyze grouped or repeated mea-
surements by linear regression. Let j be the group index, i the index of the single observation
from the group j and xi the ith row of X, (1,Xi2). Then the equation
yi |Uj , εi = xiβ + Uj + εi. (2.14)
gives the marginal distribution of yi depending on U j and εi. The random effects Uj ∼ N(0,G)
and the residual error term εi ∼ N(0, τ2) are independent from each other. Let yj be a vector
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of all observations of group j. The expectation E(yi) is still xiβ, but the covariance between the





where Dj is in the case of the random intercept model a nj × 1 matrix of 1’s, G is a scalar to
be estimated and Inj is an nj × nj identity matrix. Thus, if G 6= 0, the observations within a
group will be uniformly correlated (uniform correlation between each observation).
Nested groups can be modeled by extending the design matrix X with an additional column of
1’s and using according indices that specify the nesting structure.
An extension of the random intercepts model is the random slopes model, which allows for
additional, group-specific slopes with respect to a explanatory variable x. It can be implemented
by modifying (2.14). Let Uj be a two-dimensional random vector with a 2×2 covariance matrix
G. Again, we can specify the marginal distribution of a observation i within a group j:
yi |Uj , εi = xiβ + xiUj + εi. (2.16)
Dj is a ni × 2 equal to all rows of observations of j in X. The covariance matrix Vj for
group j is defined as in equation (2.15), using the new Dj . Defining xj as the matrix with all












with m being the number of groups and V̂j being the estimated covariance, obtained by maxi-








j xj and V̂j are assumed to be positive definite . The approximate









Weights can be introduced by replacing Inj in (2.15) with the previously introduced weight
matrix Wj . Hypothesis tests for β = βH0 can be made using the Wald method.
It is necessary to check the model assumptions after fitting a linear regression. For this purpose,
fitted values can be plotted against standardized residuals. If the standardized residuals are not
dispersed evenly around zero for any size of fitted values, the assumption of the residuals being
independently and equally distributed around zero is violated and estimates are biased.
2.5 Publication Bias Assessment
The tests that will be presented on the following pages are a common way to detect publication
bias. A frequently used method to test and adjust for publication bias, which goes under the
name of trim-and-fill (Duval and Tweedie, 2000), is not discussed because of its disadvantageous
properties (see e. g . Moreno et al., 2009).
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2.5.1 Begg and Mazumdar: Rank Correlation Test
Begg and Mazumdar (1994) proposed a rank based test to test the null hypothesis of no correla-
tion between effect size and variance. A standardized effect size θ?i can be computed as in (2.18).
se2?i is the variance of θi − θM as defined in (2.19) and θM is the fixed effects pooled treatment
effect ((2.5).









A rank correlation test based on Kendall’s tau is then used. First, the pairs are ordered
after their ranks based on se2?. Then, for each se2? rank, the corresponding ranks based on θ2?
that are larger are counted and summed up to u. The number of ranks based on θ2? that are
in contrary, smaller, are counted and summed up to l. Then the normalized test statistic Z is
given as
Z = (u− l)/
√
n(n− 1)(2n+ 5)/18.
Thus, large number of concordant pairs will reflect in large û and small l̂ and thus lead to a
large Ẑ. A two-sided p -value is obtained using the standard normal distribution Φ:
p = 2 · (1− Φ(|Z|)).
A one-sided test for positive correlation is obtained by computing 1 − Φ(Z) instead. The
changes that have to be made in the case of ties are small and can be found in Armitage et al.
(2008).
2.5.2 Egger’s Test: Weighted Linear Regression Test
Linear regression can be used to test dependency of effect sizes on study sizes. The simplest
application was introduced by Egger et al. (1997). Let θ/ se be the dependent variable y and
1/ se the explanatory variable x. If plotted, this corresponds to a radial or Galbraith plot
(Galbraith, 1988). The linear regression equation as introduced before in (2.10) can be written
in two ways:
θ/ se = β0 + β1/ se +ε, ε ∼ N(0, σ2). (2.20)
Equation (2.20) is often provided due to the correspondence to the radial plot. However, it
is equivalent to
θ = β0 + β1 se +ε, ε ∼ N(0, w−2σ2) (2.21)
with weights w = 1/ se2. Thus testing β0 of (2.20) or β1 of (2.21) is equivalent. The corresponding
p -value is then used as evidence for a small study effect. Plugging in θi/ sei, 1/ sei as yi, xi into
equations (2.12) and (2.13) will give the estimates for β̂0, β̂1, ŝeβ0 and ŝeβ1 .
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2.5.3 Thompson and Sharp’s Test: Weighted Linear Regression Random Ef-
fects Test
A method proposed in Thompson and Sharp (1999) allows for between study variance τ2, as
introduced before in section 2.3. It extends the previously seen linear regression approach with
x = 1/ se and y = θ/ se by introducing new weights. The effect size θi is assumed to be distributed
as
θi ∼ N(β0 + β1 sei, se2i +τ2). (2.22)




2). After adjusting for the weights as described in 2.4, we can proceed analogous to
Egger’s test. The p -value for β0 6= 0 reflects the evidence for a small study effect.
2.5.4 Peters Test: Weighted Linear Regression Test
When the outcome is dichotomous, effect sizes and variances of effect size are correlated, which
can readily be seen in (2.3) and (2.4) (see also (Schwarzer et al., 2015, p. 120)). A small number
of event counts in one or group will inflate the variance and the effect size. Consequently, the
tests above will tend to reject the null-hypothesis too often, i. e. report false positives.
Instead of taking the standard error se as explanatory variable x as in Egger’s test, the inverse
of the total sample size is used. Additionally, the variances se2i are used as weights. Thus, the
subsequent test procedure is identical to Egger’s test. Peters test is a a small modification of
Macaskill’s test where the explanatory variable is the sample size instead of its inverse.
The method will give less false positives than Egger’s test, but will be more imprecise, because
total sample size is not a very good approximation for statistical power (the overall rate of events
in both groups plays an important role as well).
2.5.5 Harbord’s Test: Score based Test
An alternative to Peters test for binary outcomes is Harbord’s test (Harbord et al., 2006). It uses
a different treatment effect and variance estimate: the score ϕ of the log-likelihood, evaluated as
log odds ratio θH0 = 0 and its inverse Fisher information se2. Formally,
ϕ = et − (et − ec)(et + (nt − et))/(nt + nc)
se2 =
(et + ec)(et + (nt − et))(ec + (nc − ec))((nt − et) + (nc − ec))
(nt + nc)2(nt + nc − 1)
.
It can be shown that they are both good approximations of the log odds ratio and its variance
if the real θ is not too far from zero. The standardized estimate ϕ/ se2 is also known as Peto
odds ratio. The obtained scores and variances can be used in Egger’s test as treatment effects
and variances.
2.5.6 Schwarzer’s Test: Rank Correlation Test
Schwarzer et al. (2007) developed a test for the correlation between the event counts in the
treatment group and the expected event counts Et − E(Et), where Et is a random variable.
When the marginals in a two-by-two table and the log odds ratio are fixed, it can be shown that
Et follows a non-central hypergeometric distribution. Using the Mantel-Haenszel log odds ratio
and the marginal total parameters, the variance and the expectation of Et is calculated. The
inverse of the variance se(Et)2 and the standardized event count
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(et − E(Et))/ sei (2.23)
are then used as before in Begg and Mazumdar’s test.
2.5.7 Rücker’s Test: Using the Variance Stabilizing Transformation for Bi-
nomial Random Variables
The correlation between variance and effect size of dichotomous outcome measures can be abol-
ished by the variance stabilizing transformation for binomial random variables. We use that the
arcsine function is the variance stabilizing transformation for a proportion. Let
θi = arcsin (et/nt)− arcsin (ec/nc) se2i = 1/(4nt) + 1/(4nc).
Then one can optionally apply Begg and Mazumdar’s rank correlation test or Thompson and
Sharp’s test using the newly obtained estimates.
2.5.8 Excess Significance Test
Publication bias does not need to be accompanied by small study effects. In the absence of any
treatment effect, significant effects could be included in a meta-analysis on both directions of
treatment effects (i. e. large and small effects) are published. Also, the afore-mentioned methods
do not use statistical significance directly to investigate publication bias. Thus, a different test
is introduced.
Ioannidis and Trikalinos (2007b) developed an exploratory test to detect if the proportion of
significant findings is larger than expected. We assume that the effects are equally distributed
around a true mean effect θM , which can be estimated by fixed effects meta-Analysis (2.5). Let
O be the number of significant study results out of n studies and α the significance threshold.
Corresponding to the study effect θi, we can specify the power 1 − βi, the probability to be
accepting a true result. Let zα,i be the 1 − α quantile of a normal distribution with standard
error ŝei. The power of study i can be estimated as:
1− β̂i = F (zα) (2.24)
with F being the cumulative normal distribution with mean θ̂M and standard deviation ŝei.














and consecutively, calculating a p -value for the evidence against the null-hypothesis of O = E
with a χ2 distribution with one degree of freedom. Alternatively, one can also use a binomial
test, which is encouraged when n and O is small. We will get a one sided p -value for excess









with p = E/n and X being a binomial random variable with probability p.
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2.6 Publication Bias Adjustment
There are different approaches to correct for small study effects and publication bias. They can
mainly be distinguished by their underlying methods: regression based approaches aim to regress
the effect to a study with infinite precision (i. e. very small standard error) or to a summary
effect, corrected for publication bias. Selection models are used for a sensitivity analysis, where
the selection parameters are assumed to be fixed.
2.6.1 Adjustment by Regression
In Rücker et al. (2010) and Rücker et al. (2011), a random effects model is proposed to obtain
unbiased treatment effect estimates. Similarly to regression based tests for small study effects,
we have





vi + τ2, (2.25)
εi
iid∼ N(0, 1). (2.26)
The only difference between Thompson and Sharp’s variant and this method is that x =√
se2 +τ2 is used instead of x =
√
se2. β1 is the bias parameter and can be interpreted as the







→ β1 if sei →∞
E(θi)→ β0 + β1τ if sei → 0.
After estimating τ2, one can estimate β0 and β1 as seen before in the simple linear regression
framework.There are two possible estimates at hand:
• β0 the treatment effect without any influence of study precision with standard error seβ0
• β0 +β1τ the treatment effect of a hypothetical study with infinite precision, corresponding
standard error se = seβ0 + seβ1
Simulations in Rücker et al. (2011) suggested that the latter estimate is slightly superior to
the former, because it showed a smaller mean-squared error in simulation studies Rücker et al.
(2010). From the formulas above, it becomes clear that is has a larger standard error. The
results of the simulation furthermore emphasize that adjustment is more reliable when effects of
publication bias are strong within a meta-analysis. When no publication bias affects the meta-
analysis, and event rates are low, the method provided biased estimates and the mean squared
error was large. The coverage of the confidence intervals was always larger or equal to meta-
analysis. It outperforms or is equal to classical meta-analysis estimates with respect to coverage,
mean squared error and bias if there is publication bias, especially if event rates in the control
group are small.
2.6.2 Copas Selection Model
A method proposed in Copas and Shi (2001), Copas and Shi (2000) and Copas and Malley (2008)
assumes that study results are selected based on the specific properties of their effect sizes and
variances.
Let θi be the effect size estimate of study i. Then
θi ∼ N(µi, σ2i ) µi ∼ N(θ, τ2) (2.27)
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which is identical to the random-effects meta-analysis setting. θ is the population mean effect,
σ2i the within study variance and τ
2 the between study variance. This is termed the population
model.
The selection model is defined as follows. Suppose a selection of studies with reported standard
errors se (possibly different from σ). Only a proportion of the selection will be published, with the
parameter a defining the overall proportion of published studies and b (assumed to be positive)
defining how fast this proportion increases with se becoming smaller. Formally, the probability
of selection given a reported standard error se is defined as
P (select | se) = Φ(a+ b/ se).
The equation can be rewritten as
z = a+ b/ se +δ
with δ ∼ N(0, 1). z is interpreted as the propensity for selection. It is defined that the sign of z
must be positive in order for the study to be selected. a is some kind of global selection rate for
each study and b decides about the decline of selection probability with increasing se.
So far, we have, for a study i
θi = µi + σiεi
µi ∼ N(θ, τ2)
zi = a+ b/ sei +δi
where (εi, δi) are standard normal residuals. The two models are coupled by introducing a
correlation ρ = cor(θi, zi) by defining (εi, δi) as bivariate standard normals. It follows that, if ρi
is unequal to zero and positive and zi > 0, then the estimate of a study i that is selected is likely
to have positive δi and thus positive εi, such that the true mean µ is likely to be overestimated.
Let ui = a+ b/ sei, λ(ui) the Mill’s ratio φ(ui)/Φ(ui) (φ is the standard normal density function
and Φ the cdf) and ρ̃i = σ/
√
(τ2 + σ2i )ρi. The probability of a study being selected, given sei
and θi, is
P (select | sei, θi) = Φ
(
ui + ρ̃i((θi − µ)/
√




Which shows that larger sei and θi lead to a larger selection probability. It can also be shown
that the expected value
E(θi | sei, select) = µ+ ρiσiλ(ui) (2.28)
increases for larger σ.
A likelihood for θi, conditional on z > 0 can be formulated to estimate the parameters of the
model. a and b are not estimated because the number of missing studies and their effect sizes
is not known. Instead, fixed values for a and b have to be imputed. The nuisance parameter σi
can be estimated, as
Var(θi | sei, zi > 0) = σ2i (1− c2i ρ2i ).
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With equation (2.28), one can obtain fitted values of θi based on sei and fixed a and b. For two
different pairs (a, b), (a?, b?),
E(θi | zi > 0, a?, b?)− E(θi | zi > 0, a, b) ≈ c? + ρ(λ(a?)− λ(a)) sei .
Local departures of two fitted values of θi can be approximated by adding a linear term in sei
to the expectation of θi. Thus, to test a single pair (a, b) (chosen such that ρ ≥ 0), it is sufficient
to test β 6= 0 in
θi = θ + β sei +σiεi.
If β 6= 0, there is still bias in the fitted values. To test a pair (a, b) against the scenario with
no selection, we set a? =∞ (or ρ = 0) and b? = 0. A likelihood ratio test will give a test statistic
to test against H0 = no selection (β 6= 0):




L̃(θ, τ, 0)) (2.29)
with





log(τ2 + σ2i ) +
(θi − θ − β sei)2
(τ2 + σ2i )
]
.
χ2 can be used with a χ2 distribution with one degree of freedom to obtain a p -value. Note
that the test is very similar to Egger’s small study effect test when τ2 = 0.
In practice one can observe how θ and it’s confidence intervals change dependent on the under-
lying selection process, and how the choice of the parameters affect the evidence for remaining
publication bias (selection). Rücker et al. (2011) used the method in a simulation for infer-
ence purposes, and have implemented it in the Schwarzer (2007). However, in the simulations,
the method was outperformed by the regression adjustment method when publication bias was
present. Especially when event rates in the control group were small and publication bias was
strong, bias, mean squared error and coverage was substantially worse. Other authors argue that
selection models should in general not be used for inference (e. g . McShane et al., 2016).
The procedure in Rücker et al. (2011) is the following: A range of values of (a, b) are applied, and
the test for residual small study effect as described in equation (2.29) is applied. If all obtained p
-values from the test are above a threshold 0.1, this is interpreted as no evidence, and no need for
adjustment, and the standard, classical random effects meta-analysis is retained. If none of the p
-values is above the threshold, a wider range of values for (a, b) is used. When some p -values are
above, and some below the threshold, the pair (a, b) with the smallest number of missing studies
is retained (that is, the pair of a and b that implies the fewest publication bias is chosen).
Currently, there is no test to detect miss-specifications in the model itself and the authors them-
selves have argued that a non-parametric test of the residuals would lack power.
2.7 Transformation between Effect Measures
Assuming that binary outcomes result from a dichotomization of originally continuous random
variables, binary outcome measure can be transformed into continuous outcome measures. Here,
the logistic distribution is used to achieve the transformation from a typical binary effect measures
to a std. mean difference (Borenstein et al., 2011, 47).
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Let θ be a log odds ratio and se it’s standard error. The std. mean difference d and it’s variance













= 1.81 is the standard deviation of the logistic distribution L(µ, η) with scale
parameter η = 1, so we just divide the log odds ratio and it’s variance through the standard
deviation. The approximation works only well if et and ec are not very small, especially in the
case of se2d.




a = (nc + nt)
2/ncnt
where a is a correction factor if nt 6= nc (Hedges and Olkin, 1985, Borenstein et al., 2011).





Because r and ser are not independent, we can apply a variance stabilizing transformation.
Finally, we can get to a Fisher’s z-score and it’s variance se2z by using:









z is approximately normally distributed with around the mean z and with standard error sez.
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Chapter 3
The Cochrane Dataset
3.1 Cochrane Systematic Reviews
Cochrane has specialized on systematic reviews in clinical science. Certain knowledge of stan-
dards and principles of the organization may help to understand the dataset. The following
information stems from the Cochrane Handbook for Systematic Reviews (Higgins JPT, 2011).
The definition of a systematic review is that it “attempts to collate all empirical evidence that
fits pre-specified eligibility criteria in order to answer a specific research question.” Thus, the
“key properties of a review are”:
• “a clearly stated set of objectives with pre-defined eligibility criteria for studies”
• “an explicit, reproducible methodology”
• “a systematic search that attempts to identify all studies that would meet the eligibility
criteria”
• “an assessment of the validity of the findings of the included studies, for example through
the assessment of risk of bias”
At the end of a systematic review, “a systematic presentation, and synthesis, of the charac-
teristics and findings of the included studies” is done.
Fifty three Cochrane Review groups prepare and maintain the reviews within specific areas of
health care. A group consists of “researchers, healthcare professionals and people using health-
care services (consumers)”.
The groups are supported by Method groups, centers and fields. The Cochrane Method groups
aim to discuss and consult the groups in methodological questions concerning review preparation.
The centers play a main role in training and support of the groups. The fields are responsible
for broad medical research areas and follow priorities in those areas by advice and control of the
groups.
The first step in a review is writing a protocol, specifying the research question, the methods
to be used in literature search and analysis and the eligibility criteria of the study. Changes in
protocols are possible but have to be documented and the protocol is published in advance of
the publication of the full review. The choices of methodology as well as the changes should not
be made “on the basis of how they affect the outcome of the research study”.
In order to avoid potential conflicts of interests, there is a code of conduct that all entities of
Cochrane have to agree on: conflicts of interest must be disclosed and possibly be forwarded to
the Cochrane center, and participation of review authors in the studies used have to be acknowl-
edged. Additionally, a Steering group publishes a report of potential conflicts of interests based
on information about external funding of Cochrane groups.
In order for keeping the reviews up-to-date, they are revised in a two-year circle with exceptions.
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In addition to inclusion of new evidence in a field, the revision and maintenance process may as
well includes change in analysis methods. This can reflect some advance in clinical science as for
example new information about important subgroups, as well as new methods for conducting a
Cochrane review. However, there are no clear guidelines and the Cochrane groups are free in the
rate and extent of up-dating their reviews.
3.1.1 Methods for Cochrane Reviews
A research question defines the following points: “the types of population (participants), types
of interventions (and comparisons), and the types of outcomes that are of interest”. From the
research question, usually the eligibility criteria follow. Usually, outcomes are not part of eligi-
bility criteria, except for special cases such as adverse effect reviews.
The type of study is an important eligibility criterium. Cochrane focuses “primarily on ran-
domized controlled trials”, and also, the methods of study identification in literature search are
focused on randomized trials. Furthermore, study characteristics such as blinding of study oper-
ators with respect to treatment and cluster-randomizing might be additional eligibility criteria
which have to be chosen by the review authors.
After having specified the eligibility criteria, studies have to be collected. The central idea of
systematic reviews, and also meta-analyses, is that the collected studies are a random sample
of a population of studies, i.e. that they are representative and can be used to assess popula-
tion properties. Therefore, the search process is crucial, as a selective search result may impose
bias on the sample of studies available, making it a non-random sample. For this purpose, the
Cochrane groups are advised to go beyond MEDLINE, because a search restricted to it has been
shown to deliver only 30% to 80% of available studies. “Time and budget restraints require the
review author to balance the thoroughness of the search with efficiency in use of time and funds
and the best way of achieving this balance is to be aware of, and try to minimize, the biases such
as publication bias and language bias that can result from restricting searches in different ways.”
It is important to note that not only studies, but also study reports are occasionally used in the
reviews, as they may provide useful information.
There are different sources that are being used to search for studies.
• The Cochrane Central Register of Controlled Trials is a source of reports of controlled
trials. “As of January 2008 (Issue 1, 2008), CENTRAL contains nearly 530,000 citations
to reports of trials and other studies potentially eligible for inclusion in Cochrane reviews,
of which 310,000 trial reports are from MEDLINE, 50,000 additional trial reports are from
EMBASE and the remaining 170,000 are from other sources such as other databases and
handsearching.” It includes citations published in many languages, citations only available
in conference proceedings, citations from trials registers and trials results registers.
• MEDLINE. MEDLINE includes over 16 million references to journal articles. 5,200 journals
publishing in 27 languages are indexed for MEDLINE. PubMed gives access to a free version
of MEDLINE with up-to-date citations. NLM gateway such as the Health Services Research
Project, Meeting Abstracts and TOXLINE Subset for toxicology citations allows for search
in both databases together with additional data from the US National Library of Medicine.
• EMBASE. 4,800 journals publishing in 30 languages are indexed in EMBASE, which in-
cludes more than 11 million records from 1974 onward. EMBASE.com also includes 7
million unique records from MEDLINE (1966 up to date) together with its own records.
Additionally, EMBASE Classic allows access to digitized records from 1947 to 1973. EM-
BASE and MEDLINE each have around 1,800 journals not indexed in any other database.
• Regional or national and subject specific databases can additionally be consulted and
often provide important information. Financial considerations may limit the use of such
databases.
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• General search engines such as Google Scholar, Intute and Turning Research into Practice
(TRIP) database can be used.
• Citation Indexes. The database lists articles published in around 6,000 journals with arti-
cles in which they have been cited and is available online as SciSearch. This form of search
is known as cited reference searching.
• Dissertation sources. Dissertations are often listed in MEDLINE or EMBASE but one is
advised to also search in specific dissertation sources.
• Grey Literature Databases. Approximately 10% of the results in the Cochrane Library
stems from conference abstracts and other grey literature. The Institute for Scientific and
Technical Information in France provides access to entries of the previously closed System
for Information on Grey Literature database of the European Association for Grey Litera-
ture Exploitation. Another source is the Healthcare Management Information Consortium
(HMIC) database containing records from the Library and Information Services depart-
ment of the Department of Health (DH) in England and the King’s Fund Information
and Library Service. The National Technical Information Service (NTIS) gives access to
the results of US and non-US government-sponsored research, as well as technical report
for most published results. References from newsletters, magazines and technical and an-
nual reports in behavioral science, psychology and health are provided in the PsycEXTRA
database which is linked to PsycINFO database.
3.2 Structure and Variables
The dataset consists of 6,354 systematic reviews from the Cochrane Library with 70,662 studies
and 744,720 results. A result of a study can be a primary or secondary or safety outcome, thus
studies can contribute multiple results. The studies too a very large extent randomized and
investigate the effects of healthcare and medical interventions and treatments. The reference to
the treatment may be a placebo control or a different intervention or treatment. A result can
not only be about efficacy of the treatments, but also about safety (adverse effects).
It will be continued with an example form the dataset. In Table 3.1, two results from a systematic
review about barbiturates are shown as they are given in the dataset. As can be seen, further
specifications are provided by the variables in the columns.
The comparison.name variable specifies what kind of treatments or interventions are compared,
the outcome.name variable how it is compared, and the subgroup.name variable (not indicated
in table) if and to what experimental subgroups the results belong to.
The result is of a binary type, and the counts of events in the treatment group are in events1
and of the control group in events2 and the total number of participants are given in columns
total1 and total2. As can be seen, events denote here "death at the end of follow-up".
study.name comparison.name outcome.name events1 total1 events2 total2
Bohn 1989 Barbiturate vs no barbiturate Death at the end of follow-up 11 41 11 41
Ward 1985 Barbiturate vs no barbiturate Death at the end of follow-up 14 27 13 26
Table 3.1: Example of results from two primary studies that belong to the same
comparison and outcome. Events denotes the count of events in the treatment group
while Events c the count of events in the group compared to. Further descriptive
variables have been ommitted.
Results are part of studies that are again part of a (systematic) review. The general structure
of a review is shown in Figure 3.1.
A listing of important variables of a result is given in Table 3.2. Depending on the type of
the data, e. g . if it is binary or continuous, some variables are missing for the specific results.










Figure 3.1: General structure of the database. Results from primary studies that
belong to the same comparison, outcome and subgroup can be used to estimate a
combined effect in a meta-analysis.
The structure of a review will now be outlined based on an example of the dataset. The
previously mentioned barbiturate and head injury review will be outlined. The aim was to
“assess the effects of barbiturates in reducing mortality, disability and raised ICP (intra-cranial
pressure) in people with acute traumatic brain injury” as well as to “quantify any side effects
resulting from the use of barbiturates” The review comprises five studies in total. Three of
them compared barbiturate treatment to placebo, one compared barbiturate to Mannitol and
one Pentobarbital to Thiopental. The studies have different outcomes, for example, death or
death and severe disability at follow up, but also dropout counts or adverse effects (secondary
outcomes). We have continuous (e.g. mean body temperature) and binary outcome data (e.g.
death/no death). One study split up outcomes for patients with and without haematoma, which
would be subgroups.
Information about missing values in the dataset is given in Table 3.4. The relative amount
of missing values is low, except for study years. For continuous outcomes, the cases are counted
were neither a mean difference nor means are available. Similarly, the counts of cases where
neither standard errors nor standard deviations are available are provided. Study years before
1920 and after 2019 are declared as missing, as well as sample sizes equal to zero.
The primary studies that are included in the reviews and have been published are most often
from the years after 1980 (5% quantile = 1982, 95% quantile = 2014,). The median of the
publication years is 2003, the mean 2001 and the quartiles are 1996 and 2008. 1,075 studies have
been published in 2018.
The most frequent outcome measures are summarized in Table 3.5. One can conclude of the
table that roughly 31% of outcomes in the dataset are continuous and the rest being some sort
of discrete or binary outcomes, most often binary (more than 65%).
The sample sizes among results vary to some extent. There are 5% of treatment group sample
sizes that are smaller than 9, 95% smaller than 510. The first quartile is 23, the median 48, the
mean 257 and the third quartile 116. The large difference between median and mean is caused
by very large groups with over 2,000,000 participants. Analogously, the quantiles of the total
sample size are: 5% quantile = 17, first quartile = 44, median = 94, third quartile = 223 and
95% = 983. The mean is 623.
There are 519 reviews with five or fewer results. The 5% and 95% quantiles are 4 and 447. The
mean and median number of results per review are 13.6 and 8, and the quartiles are 16 and 109.
Similarly, the number of reviews with a maximum of two studies included is 1,040, the mean
study number is 13.6, the median 8 and the interquartile range 4 and 16 and the 95% quantile
45. The discrepancy between mean and median is due to large reviews with a high number of
studies and results, most extreme in which is a systematic review about antibiotic prophylaxis
for preventing infection after cesarean section, with 95 studies and 1,497 results in total.
For results to be suitable for usage in meta-analysis, they have to be identical with respect to
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Variable Description
id An id of the review for identification purposes.
study.name Name of the study to which the result belongs.
study.year Year in which the study was published.
comparison.name/.nr Specification of the interventions compared in the study and a
unique number for the comparison.
comparison.id Specification of the comparison by a string of the type “CMP-xxx”
for the xxx. comparison within the review.
outcome.name/.nr Specification by which outcome the interventions are compared
and a unique number for the outcome.
outcome.id Specification of the outcome by a string of the type
“CMP-xxx.xx” for the xx. outcome of the xxx. comparison
within the review.
subgroup.name/.nr Potentially indication of affiliation to subgroups and a unique
number for the subgroup.
subgroup.id Specification of the comparison by a string of the type
“CMP-xxx.yy.xx” for the xx. subgroup for the yy. outcome
of the xxx. comparison within the review.
outcome.measure Outcome measure, for example risk ratio.
outcome.measure.merged Outcome measure, for example risk ratio, merged such
that each method is uniquely classified.
outcome.flag A outcome flag to simplify programming;
DICH for binary outcomes with fully available information
on event counts, as given in a two-by-two
table.
CONT for continuous outcomes with available means and
standard deviations.
IV for all results with effects and standard errors but without
the data necessary for their computation.
IPD for individual patient data.
effect Magnitude of the effect given in the quantity denoted by
outcome measure.
se Standard error of the measure of the effect.
events1/events2 The counts of patients with an outcome if measurement/outcome
is binary or dichotomous (1 for treatment group and 2 for control group).
total1/total2 Number of patients in groups.
mean1/mean2 Mean of patient measurements if outcome is continuous.
sd1/sd2 Standard deviation if outcome is continuous.
Table 3.2: Dataset variable names and descriptions.
comparison and outcome. The studies in the dataset that have the same comparison, outcome
and subgroup can be pooled in a meta-analysis. This distinction is also used by Cochrane, i. e.
the meta-analyses are identical to the meta-analyses done in the systematic reviews.
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study.name comparison.name outcome.name
Bohn 1989 Barbiturate vs no barbiturate Death at the end of follow-up
Bohn 1989 Barbiturate vs no barbiturate Death or severe disability at the end of follow-up
Eisenberg 1988 Barbiturate vs no barbiturate Death at the end of follow-up
Eisenberg 1988 Barbiturate vs no barbiturate Uncontrolled ICP during treatment
Eisenberg 1988 Barbiturate vs no barbiturate Hypotension during treatment
Perez-Barcena 2008 Pentobarbital vs Thiopental Death at the end of follow-up (6 months)
Perez-Barcena 2008 Pentobarbital vs Thiopental Death or severe disability at the end of follow-up (6 months)
Perez-Barcena 2008 Pentobarbital vs Thiopental Uncontrolled ICP during treatment
Perez-Barcena 2008 Pentobarbital vs Thiopental Hypotension during treatment
Schwartz 1984 Barbiturate vs Mannitol Death at the end of follow-up (1 year)
Schwartz 1984 Barbiturate vs Mannitol Death at the end of follow-up (1 year)
Schwartz 1984 Barbiturate vs Mannitol Uncontrolled ICP during treatment
Ward 1985 Barbiturate vs no barbiturate Death at the end of follow-up
Ward 1985 Barbiturate vs no barbiturate Death or severe disability at the end of follow-up
Ward 1985 Barbiturate vs no barbiturate Mean ICP during treatment
Ward 1985 Barbiturate vs no barbiturate Mean arterial pressure during treatment
Ward 1985 Barbiturate vs no barbiturate Hypotension during treatment
Ward 1985 Barbiturate vs no barbiturate Mean body temperature during treatment
Table 3.3: Barbiturate and head injury review. In the columns, study names, com-
parison and outcome measure of the results are given.
Neither means nor standard deviations (CONT) 775
Zero participants in one group 15162
Missing study publication year 7834
Table 3.4: Number of missing variables and measurements in the dataset.
3.3 Data Tidying and Processing
3.3.1 Newly Introduced Variables
Some new variables are added to the obtained dataset:
• lrr and var.lrr: log risk ratio and variance of the log risk ratio for outcome.flag DICH.
• cohensd and var.cohensd: Cohen’s d and the variance for outcome.flag CONT.
• smd.ordl and var.smd.ordl: Cohen’s d and its variance as obtained by transformation of
a log odds ratio for outcome.flag DICH.
• cor.Pearson and var.cor.Pearson: Pearson correlation coefficient and variance as ob-
tained from the d (for outcome.flag DICH) or d (for outcome.flag CONT) to r transforma-
tion.
• z and var.z: Fisher’s z score and it’s variance obtained from the Pearson correlation r to
z transformation.
• pval.single: p-value against the null hypothesis of no treatment effect, derived by a t-test
for outcome.flag CONT or Wald test for outcome.flag DICH.
• events1c and events2c: Correction of events1 and events2 zero event counts or event
counts = patient number. When no events occurred, 0.5 was added, and when all patients
experienced the event, 0.5 was subtracted. When one of events had zero counts while the
other had maximum counts, no adjustment occurred.
• meta.id: Meta-analysis ID variable to uniquely identify any potential meta-analysis in the
dataset. Consistent to what has been discussed before, all results that share a common
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Hazard Ratio 8054 1.1%
Rate Ratio 3724 0.5%
other 8555 1.1%
Table 3.5: Frequencies of outcome measures among results.
comparison, outcome and subgroup (optional, subgroups not given in any case) may be
combined in a meta-analysis.
• smd.pool and se.smd.pool: Depending on outcome.flag, smd.pool is equal to smd.ordl
(outcome.flag = DICH), cohensd (CONT), or effect (IV and outcome.measure.merged =
SMD). or se (IV).
3.3.2 Eligibility criteria for Publication Bias Test and Adjustment
The analysis includes all results with outcome.flag DICH, CONT and IV. If outcome is IV, the
only meta-analyses with outcome.measure.merged = OR / RR / SMD / MD / Hazard Ratio / Rate
Ratio are used. Ioannidis and Trikalinos (2007a) outlined criteria for application of small study
effect tests:
• Sample size: A meta-analysis is comprised of at least ten studies (n = 9,772 remaining).
• Study size: The ratio between largest variance of an estimate and smallest variance of an
estimate is larger than four (n = 9,473 remaining).
• Significance: At least one treatment effect has a p-value below the significance threshold
0.05 (n = 7,452 remaining)
• Heterogeneity: The I2 statistic of a given meta-analysis is smaller than 0.5, thus, the
proportion of between study variance of the overall variance is smaller than 0.5 (n = 1,388
remaining).
Additionally, the following criteria have been applied:
• Sensitivity Analyses: When the same results are used multiple times for different meta-
analyses, only one is retained. More precisely, if a study hat the same study.name and
same effect, it was considered a duplicate, and the smaller meta-analysis of the two was
excluded. The intention is to exclude sensitivity analyses which are operated on subsets of
the available results.
• Zero events: In the case of binary outcomes, meta-analyses with zero events in any study
and any group are excluded (n = 20 out of meta-analyses with at least ten studies).
• No withdrawn reviews: Reviews that have been withdrawn are not included.
• No adverse effects: No results of adverse effects of treatment are used for meta-analysis.
We could thus clearly identify many safety results but this may be incomplete when safety
outcomes are insufficiently declared, for example “headache”.
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The results of this reduction of the dataset are shown in the flow-chart in Figure 3.2. Only
the data that had accessible all results data available was used for adjustment. Thus, all meta-
analyses with outcome.flag == IV and outcome.measure.merged not equal to SMD are omitted
in a second step of the analysis (Analysis dataset (1) and (2) in Figure 3.2).
Exclusions for other Reasons
In some more cases, meta-analyses were excluded because their results seemed to be erroneous (1)
or because participant numbers were missing (5), necessary to compute the variance of Fisher’s z
transformed correlation coefficient. The latter meta-analyses (all outcome.flag = IV) were only
omitted when doing the adjustment based on the Fisher’s z transformed correlations, but kept
when adjusting based on std. mean differences. The meta-analysis that is considered erroneous
is from a review with the title “School-based programs for preventing smoking”. The reason why
it is suspected to be erroneous is because there are results from one study (Severson, 1991) with
rather large effects (13, 0.4, 6.3, 2.4) compared to a mean std. mean difference in 12 other results
of 0.22 (max.: 0.91) and very large standard errors (64, 60, 46, 70) compared to a mean se of
0.6 (max.: 3.8). It is not included in the analysis.
The Analysis Dataset
The dataset that was ultimately tested and adjusted for publication bias comprises 1,388 meta-
analyses and 22,937 results. The mean number of participants in the treatment group is 253.5
vs 256.7 in the complete dataset and the mean total number of participants 589.3 vs 623.2. The
mean publication year is 2000 vs 2001 in the complete dataset.
From the meta-analyses with incomplete data (outcome.flag == IV), there are 36 meta-analyses
with
outcome.measure.merged = RR, 26 SMD, 25 Hazard Ratio, 15 OR, 11 MD and 8 Rate Ratio.
3.3.3 Analysis Procedure
Meta-analysis within a review were obtained by grouping by comparison, outcome and subgroup.
The last step is optional, and the Cochrane groups do also meta-analysis without taking into
account subgroups. Subgroups are often specifications of treatment, e. g . the form of the medi-
cation or the protocol. Thus, using the subgroups should increase the within-study homogeneity.
However, the Cochrane disencourages meta-analyses based on subgroups only, because subgroups
are often set up after the collection of the data analysis. Since the main interest of this study
is not to precisely assess the efficacy of treatments, but the interest is merely on systematic
differences between single studies investigating the same scientific question and not in the effect
per se, it has been decided that the increase in precision is worthwhile the loss of a number
of studies. While it is possible that the use of subgroups introduces bias in the meta-analysis,
it is also possible that ignoring subgroups will do (which is one of the reasons why subgroups
are analyses as well). When one subgroup has substantially different real treatment effects, and
the specific properties influence study size, publication bias assessment fails. Subgroups are not
indicated in 50.8% of the meta-analyses in the analysis dataset 1, thus, there the analyses are
identical to the overall analyses that the Cochrane Review groups did.
The methods described in the methods chapter 2 most often apply directly to the algorithms
used in meta and metafor.
For applying publication bias tests and adjustment methods, the analysis was applied such that
the effects used are similar or identical to the effects on which journal editors decided upon
publication bias. For outcome.flag = DICH, log risk ratios were used as treatment effect esti-
mates in the meta-analysis, for outcome.flag = CONT, mean difference or standardized mean
difference, depending on outcome.measure.merged. For outcome.flag = IV, the effect and
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se as provided in the dataset was passed to meta::metagen. Since the intuition behind small
study effect tests is that effects with larger standard errors have to be larger to reach significance,
the publication bias tests and adjustments are most meaningful if the effects are used in their
original scale. Transformation will change the relative size of uncertainty estimates and effects.
To be able to compare the effects of adjustment among meta-analyses, the effect sizes were trans-
formed on a common scale, as described in section 2.7. As shown in the flow-chart in Figure 3.2,
this leads to a reduced dataset (compare analysis dataset (1) and (2)). The p-values for adjusted
treatment effect estimates were calculated by the Wald method.
In the case of the one-sided test procedure (small study effect and excess significance tests), the
effect side in which bias was expected had to be pre-specified. This was solved by comparing the
number of significant findings on each side (original effect scale, i.e. for binary outcomes log risk
ratios, etc.); the side with more significant findings (two-sided p-value < 0.05) was considered
the side of potential bias. If numbers were equal, the side of the fixed effects treatment was used.
Details to Copas selection model algorithm and its application can be found in Rücker et al.
(2011). In short, two values for a and b in section 2.6.2 were used; a limited range with a
between -1.7 and 2, and b between 0.16 and 0.32 was applied first (analog to a most extreme
selection process of P (select|small trial with sd = 0.4) = 0.1 and P(select|large trial w. sd =
0.05) = 0.9). If the most extreme selection process is unable to pass the significance test of no
small study effect (p-value > 0.1), then a wider range was applied (a between -5.4 and 2 and b
between 0 and 0.32). If there is still no non-significant small study effect, the result was NA.
3.4 Software
All computations were performed in the R computing environment (R Core Team, 2018). The R
packages meta (Schwarzer, 2007), metasens (Schwarzer et al., 2017) and metafor (Viechtbauer,
2010) were used for meta-analysis, small study effect tests and adjustments. The excess sig-
nificance test was adapted from van Aert et al. (2019). For data manipulation procedures, the
tidyverse packages were used (Wickham, 2017), and for plotting the ggplot2 package (Wick-
ham, 2016).
3.5 Data and Code Availability
The data of the Cochrane Library of Systematic Reviews is freely available in some countries, in
others, the rights are reserved by the Wiley publishing company. The code for data processing
and analysis can be found at https://osf.io/dbp2r/.
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Inital dataset: 6,354 reviews, 70,662 studies, 744,720 results
5,971 reviews, 66,574 studies, 705,002 results
5,952 reviews, 65,774 studies, 632,438 results
5,936 reviews, 65,296 studies, 687,517 results
1,145 reviews, 26,094 studies, 172,212 results, 9,772 meta-analyses
1,129 reviews, 25,819 studies, 166,968 results, 9,473 meta-analyses
1,052 reviews, 23,781 studies, 134,596 results, 7,452 meta-analyses
1,021 reviews, 22,183 studies, 45,888 results, 2,665 meta-analyses







Analysis dataset (2): 694 reviews, 13,581 studies, 21,482 results, 1,267 meta-analyses
exclusion of withdrawn reviews
only efficacy outcomes
outcome.flag restriction
study number ≥ 10
variance ratio > 4




outcome.flag = CONToutcome.flag = IV
outcome.measure.merged = SMD
Figure 3.2: Flow-chart of the inclusion of meta-analyses for the final analysis. The
exclusion criteria are given at the right of the arrows.
Chapter 4
Results
Meta analysis are based on results of primary studies. Therefore, in a first step, an exploratory
plot of the median effect size from primary studies and it’s dependence on the study sample size
can be shown.
The absolute value of the median Fisher’s z-score for a given sample size of a trial is shown in
Figure 4.1. The medians are calculated separately for efficacy and safety outcomes. It is clearly
visible that the absolute value of the medians for efficacy decreases with increasing sample size.
The sample size is much smaller for safety outcomes, and there appears to be no clear relationship
between effect sizes of primary studies and their standard errors.
The pattern for efficacy outcomes is the same for all common outcome measures as shown in
Figure 4.2, where the original effect size measures “log Odds Ratio”, “log Risk Ratio”, “Mean
Difference” and “Std. Mean Difference” are used (the most common measures in the dataset,
98%).
4.1 Publication Bias Test Results
The meta-analyses fulfilling the criteria from Section 3.3, are analysed with one-sided publication
bias tests and excess significance tests. The direction in which bias is expected is the one on
which more significant results of primary studies are (two-sided p-value < 0.05). The tests are
applied on the original effect size measures, since the journal editors and the researchers also
base their decisions on them. Different tests are applied depending on the outcome being binary
or continuous or if the data is only partially available (outcome.flag = IV).
Multiple tests are applied in order to compare their results. A histogram of p-values for each
test will summarize the overall evidence against the null-hypothesis of no publication bias, as
efficacy safety





















Figure 4.1: Median of the absolute Fisher’s z-score across sample size plotted against
the total sample size.
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Figure 4.2: Median of the absolute value of the original effect size across sample size
plotted against the total sample size.
displayed in Figure 4.3.
The abbreviations in Figure 4.3 are shortly explained with references to Chapter 2:
“Excess significance” denotes the excess of significant p-values testing method from Ioannidis and
Trikalinos (2007b), see 2.5.8. For continuous and IV outcomes, the names refer to:
• Egger’s test, weighted linear regression test described in Section 2.5.2
• Thompson and Sharp’s test, weighted linear regression test adjusted for between-study
heterogeneity, Section 2.5.3
• Begg and Mazumdar’s test, rank test described in Section 2.5.1
For binary outcomes, the names refer to:
• Harbord’s test, likelihood score based test (Section 2.5.5)
• Peter’s test, weighted linear regression with inverse sample size as explanatory variable
described in Section 2.5.4
• Rücker’s test, test based on the arcsine transformation of proportions, in combination with
Thompson and Sharp’s regression test (Section 2.5.7)
• Schwarzer’s test, rank based test using the expected event counts computed with the hy-
pergeometric distribution (Section 2.5.6)
The histograms in Figure 4.3 show that the tests mostly find evidence for publication bias
in the dataset. The p-values of excess significance and Schwarzer’s test are rather uniformly dis-
tributed, but notably, excess significance test, Schwarzer’s test and rank tests have been shown
to lack statistical power. The tests that are more suitable (regression based tests in general) all
have proportions of significant p-values (p > 0.1) clearly above 10 % which would be the expected
false positive rate.
In Figure 4.3, the meta-analyses with an estimated I2 of zero are depicted, because some methods
are known to only be suitable when no heterogeneity is present (excess significance test and also
Egger’s test). Other tests are specially constructed to adjust for between study heterogeneity
(Thompson and Sharp’s test and Rücker’s test). These tests find a smaller proportion of sig-
nificant results in Figure 4.3. However, this is also due to application to meta-analyses with no
between-study heterogeneity, where the methods lack statistical power. Similarly, the evidence
decreases somewhat when Rücker’s test is extended by Thompson and Sharp’s method to ac-
count for heterogeneity. The moderate decrease indicates however that the previous restriction
to meta-analyses with I2 < 0.5 is sufficient to remove meta-analyses with large heterogeneity
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102 < 0.1, 11 %
181 < 0.1, 20 %
168 < 0.1, 18 %
200 < 0.1, 22 %
172 < 0.1, 19 %
94 < 0.1, 10 %
Rücker (Thompson) Rücker (Egger) Schwarzer
Excess significance Harbord Peter
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85 < 0.1, 25 %
22 < 0.1, 6 %
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Figure 4.3: Histogram of one-sided p-values for small study effect in direction of larger
effect sizes. The testing method is indicated in the header, bin width is equal to 0.1. The
proportion of meta-analyses with significant publication bias based on the threshold of
0.1 is displayed inside the figures.
and that the test results are not heavily influenced by unaccounted between-study heterogeneity.
The p-values of tests can be summarized by computing their harmonic mean (Good, 1958). In
the case of binary tests, the p-values of Rücker’s, Peters, Harbord’s, Schwarzer’s and excess sig-
nificance tests are used, in the case of continuous and outcome.flag = IV outcomes, Egger’s,
Thompson and Sharp’s, Begg and Mazumdar’s and excess significance tests are used. This lead’s
to an overall of 20.3% significant results (pharmonic < 0.1, 19.7% outcome.flag = DICH, 20.1%
outcome.flag = CONT, 25.6% outcome.flag = IV).
4.1.1 Publication Bias Test Consistency
In a next step, the consistency between the tests is examined, e. g . if the tests identify significant
publication bias in the same meta-analyses. There is, so far, no agreement in the literature about
which of the methods are to prefer, even non regression based tests have generally low power.
The following analysis will reveal if there are e. g . testing methods that are coming to identical
results and are thus compatible/interchangeable.
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Figure 4.4: Pairs-plot for test statistics of small study effects. The lower panel gives
the Spearman correlations for the different test statistics, and the upper panel displays a
scatterplot. The colors indicate magnitude and direction of the correlation coefficients.
The rectangle with white borders displays the area within which both tests have absolute
value < 1.64 (dots inside are statistically not significant by 0.1 p-value threshold).
A simple method to check the consistency of test results is to compare scatterplots and Spearman
correlations between the test statistics. This is done in Figure 4.4. Here, there is no separation
between IV and continuous outcomes because the same publication bias tests have been used.
The upper left rectangle is displaying binary outcome results and the lower right continuous
and IV outcomes results. Also, the I2 statistic is included. Since no normally distributed test
statistic under the null hypothesis is used for excess significance tests, it is not shown here.
The observed patterns on the scatterplots differ, and some methods do align better than
others. Regression based tests as Egger and Thompsons test which are methodically almost
identical are closely aligned, which is reflected in large correlation coefficients. Continuous and
IV outcome type tests align more closely than binary outcome tests. While correlation coeffi-
cients between binary outcome tests vary between each other, Harbord’s test statistic has similar
correlation coefficients with the other small study effect test statistics.
Because scatterplots and correlation coefficients can be misleading, also a Tukey mean-difference
or Bland-Altman of transformed p-values plot is shown for four scenarios in Figure 4.5:
• For Egger’s and Thompson’s tests, which is supposedly the most similar test and should
show the least deviations and systematic errors.
• For Egger’s and excess significance tests.
• For Harbord’s and Rücker’s tests.
• For Harbord’s and excess significance tests.
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This can be justified since all tests are supposed to measure the evidence for publication bias.
For the plots, the p-values of the tests are transformed on the entire continuous scale by a logit
transformation f(x) = log( p1−p). The mean p-value ((f(p-value no. 1) + f(p-value no. 2))/2) is
then displayed against the difference between the f(p-value). If no systematic errors and biases
exist between the measurement methods, then
• the mean of the differences should be around zero (no systematic error)
• the points should scatter independently on the y-axis and no general increase or decrease
with the mean of the transformed p-values should be visible (and the linear regression fit
is flat)
There are likely systematic errors and bias between the tests, although the extent seems to
vary. Most error seems to be between small study effect tests and excess significance tests, because
the slope of the linear regression fit is likely positive. This means that the excess significance test
finds less evidence in cases when both p-values are small and more evidence when both p-values
are large, on average.
However, the confidence intervals from Figure 4.5 are very large. This suggests that additionally
to the bias correspondence between the tests is not very good in general.
The previous results suggest that the results will also differ substantially after applying the
common dichotomization of p-values. Some proportion of the meta-analyses will only be signifi-
cant using a single test, while being non-significant otherwise. This can be seen in Table 4.1. It
displays the percentage of meta-analyses with a certain number of significant test results. Very
few meta-analyses are give a significant result, independently of the test applied. Around 67%
of the dataset is not significant, no matter which test is used.
Count Binary Outcomes Continuous and IV
0 66.1 % 65.3 %
1 12.3 % 11.9 %
2 7.7 % 6.9 %
3 6.8 % 14.2 %
4 5.7 % 1.7 %
5 1.3 % -
Table 4.1: Number of significant test results per meta-analysis, separated for outcome
types. Last entry for continuous and IV outcomes is empty since one test less was
applied.
When leaving away the excess significance test, 29.5% of binary outcome tests and 31.9%
of IV and continuous outcome tests had at least one significant result. To compare significant
findings for small study effect tests and excess significance tests, Harbord’s or Egger’s test results
are compared with excess significance tests. 24.1% of binary outcome analyses had at least one of
the two test p-values being significant, and equivalently, 28.4% for continuous and IV outcomes.
The numbers change to 13.9% for binary outcomes and 18.1% for continuous and IV outcomes
after applying the Bonferroni correction. 5.1% have significant Harbord’s test result and signifi-
cant excess significance test result (2.3% with Bonferroni). Of the continuous outcomes, we have
3.9% with Egger’s test and 1.3% with Bonferroni correction.
The precise proportions of agreement in significance/non-significance are provided in Table 4.2,
i. e. the proportion of results where both tests agree on if publication bias is significant or non-
significant. A separate column provides the proportion of significant results of the test with
fewer significant results that are also significant using the test with more significant results. If
the proportion is 1, then all significant results of one test are also significant using the other test.
Linear regression based tests agree more often with other linear regression based tests, and agree-
ment between small study effect tests is in general well above 60 % (at best, 95% test agreement




















































95 % conf. int.
logit(p−value Harbord) − logit(p−value excess significance)
Figure 4.5: Mean - difference plots for logit transformed p-values. The mean of logit
transformed p-values is displayed on the x-axis and the difference on the y-axis. Blue
and red lines display the systematic error and the confidence intervals of the systematic
error (limits of agreement). In green, a linear regression fit is shown with 95% CI bands.
in significance for IV outcome.flag). The agreement on statistical significance between small
study effect tests and excess significance tests ranges from 64% to 4% (for IV and rank tests).
Note that these numbers are difficult to interpret because there are substantially less significant
results of the excess significance tests, and thus, a agreement of 100% still does not indicate
perfect compatibility/replaceability of the tests.
4.2 Small Study Effects Adjustment
4.2.1 Change in Effect Size after Adjustment
There are methods that can take into account the presence of publication bias in meta-analyses
when estimating the overall treatment effect. The methods work in a semi-automatic manner;
they will not only adjust for publication bias if smaller studies show larger effects, but also in
the opposite case. The latter results in the adjusted overall treatment effect being larger than
the unadjusted, overall treatment effect.
To compare the effects of adjustment between meta-analyses of different outcomes, the outcome
measures are transformed to standardized mean differences and Fisher’s z-scores (see section
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Agreement (overall) Agreement (significance)
Excess significance, Schwarzer 0.85 0.27
Excess significance, Peter 0.77 0.32
Excess significance, Rücker 0.79 0.43
Excess significance, Harbord 0.81 0.46
Peter, Schwarzer 0.84 0.63
Schwarzer, Rücker 0.85 0.72
Schwarzer, Harbord 0.87 0.78
Rücker, Peter 0.88 0.67
Harbord, Peter 0.87 0.63
Excess significance, Egger 0.77 0.64
Excess significance, Thompson 0.80 0.59
Excess significance, Begg 0.78 0.36
Thompson, Egger 0.93 0.92
Thompson, Begg 0.87 0.70
Egger, Begg 0.84 0.70
Excess significance, Egger (IV) 0.71 0.12
Excess significance, Thompson (IV) 0.71 0.10
Excess significance, Begg (IV) 0.74 0.04
Thompson, Egger (IV) 0.95 0.94
Thompson, Begg (IV) 0.86 0.79
Egger, Begg (IV) 0.86 0.83
Table 4.2: Overall proportion of agreement if publication bias is significant or non-
significant, and if significant only. When comparing agreement if significant only, the
proportion of the test with fewer significant results that is significant with another test
as well is shown.
2.7 for details). When comparing to unadjusted effects, fixed or random effects meta-analysis
estimates are used as references.
Figure 4.6 displays the difference between the estimated meta-analysis treatment effect and the
regression adjusted treatment effect 2.6.1, θ̂M − θ̂Adj.. The absolute value |θ̂M | is taken and θ̂Adj.
is negative if it’s sign is different from the sign of the original θ̂M . Thus, a positive difference
indicates a reduction of the original effect size, and the magnitude of the difference indicates the
extent of the adjustment.
Additionally, the test statistics of heterogeneity adjusted publication bias tests (Rücker’s and
Thompson’s test) are displayed with green color. Test statitics smaller t < 1 (light green colored)
are equivalent to no evidence for publication bias, test statistics t between one and two to weak
evidence, and above two they indicate evidence for publication bias (dark green). An adjusted
effect with evidence for publication bias can be regarded as a more realistic estimate of the
treatment effect. Some very large and very small differences have been omitted in the Fisher’s
z-scores and std. mean difference histograms; they are shown in Table 4.4.
Most often, adjustment leads to a reduction of overall treatment effect estimates, which can be
seen by the size of the bins on the positive side of the histograms. Adjustment is stronger when
random effects meta-analysis is used as reference, because it gives larger weights to small studies.
Contrary to naive expectation, we see cases with large negative adjustment, but no evidence for
small study effects. This is because the linear regression parameter estimates are large, but
estimated with high uncertainty, such that there will be few evidence for small study effects
(publication bias), but nonetheless, the adjustment will be large. It is recommended to use the
methods only in cases where there is clear evidence for publication bias. The color legend in
Figure 4.6 thus gives a sense of the confidence that is put into the adjusted effects.
Additionally, some meta-analyses with positively adjusted, larger overall treatment effects after
adjustment (left side of the histogram) have also evidence for publication bias (defined as the
tendency of small studies to show larger results because only significant results are published).
However, this is not wrong, because the effects and their variances have been transformed, and it
is possible that the shape of the funnel plot changes upon transformation; Figure 4.7 shows this
for illustrative purposes. From the left to the right, the funnel plots of meta-analyses with binary
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Figure 4.6: Histogram of the treatment effect differences between meta-analysis and
regression adjusted meta-analysis. Negative differences indicate greater adjusted effect
sizes than meta-analysis effect sizes. The bins are centered at zero and binwidth is equal
to 0.1. Deeper green color indicates more evidence for small study effects.
and continuous outcomes are shown. We see that the direction of adjustment changes depending
on the effect size measure used. Note that while the rank of the effect sizes is preserved after
transformation, the relative size and especially the ranks of the variances may vary. Therefore,
the shape of the funnel plot may also change after transformation. Also, std. mean differences
and risk ratios and their standard errors are correlated, which is not the case for Fisher’s z-scores.
Figure 4.8 shows the differences between meta-analysis and adjusted effect sizes adjusted by
Copas selection model; the model substitutes its estimates with random effect estimates when
it finds no evidence for small study effects. Therefore, the effect of adjustment by Copas can
better be seen when comparing adjusted with random effects meta analysis estimates. Again, we
clearly see that more effect sizes are adjusted downwards. Additionally, there is more coincidence
between publication bias test statistics and adjustment, i. e. positive differences are accompanied
by large positive test statistics, which is as expected.
Table 4.3 shows quantiles and means for the various differences and the overall proportion of
downward adjusted effect sizes. When std. mean difference is used as an effect measure, there
are (substantially) more reduced effect sizes. The means in Table 4.3 suggest that the average
reduction is small. To recall some other findings out of Table 4.3: 5% or 69 meta-analyses
have their Fisher’s z-score reduced by more than 0.13 by regression adjustment (and 5% or 69
increased by -0.11 or more, fixed effects reference). Also, std. mean difference is reduced by 0.39
compared to fixed effects estimates in 5% or 69 meta-analyses (or increased by 0.24).
4.2.2 Comparison of adjustment methods
Regression adjusted estimates are compared to the estimates of Copas selection model if these
are not equal to random effects meta-analysis in Figure 4.9. A Tukey mean difference plot can
reveal systematic differences and biases between the two measurement methods. Note that only
26 out of 121 IV outcome data is included when using Fisher’s z-score and std. mean differences,
since not all effects could be transformed.
No formal tests are provided, but the at least there seems to be no clear bias or systematic
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Figure 4.7: Funnel plots for two meta-analyses and different effect size measures. In
the first row, a meta-analysis with a continuous outcome, with mean differences, std.
mean differences and Fisher’s z-scores and corresponding standard errors. In the second
row for binary outcomes, a meta-analysis with binary outcomes and risk ratios, std.
mean differences and z-scores and corresponding standard errors. Vertical dashed lines
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Figure 4.8: Histogram of the treatment effect differences between meta-analysis and
Copas adjusted meta-analysis. Negative differences indicate greater adjusted effect sizes
than meta-analysis effect sizes. The bins are centered at zero and binwidth is equal to
0.1. Deeper green color indicates more evidence for small study effects.
error. The limits of agreement in Figure 4.9 are large. We conclude thus that the impact of
regression adjustment on the effect sizes is in general not substantially larger than the impact
of Copas selection model in the subset of data where the estimate of the Copas selection model
is not equal to a random effects estimate. There is however a small difference, indicating that
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5% 25% 50% 75% 95% mean = 0 (%) ≥ 0 (%) > 0 (%) No adj. est. (%)
z: Fixed - Copas -0.05 -0.01 0.00 0.01 0.05 0.00 6.20 48.70 42.51 65.20
z: Random - Copas -0.00 0.00 0.00 0.00 0.05 0.00 66.43 85.66 19.24 65.20
z: Fixed - Regression -0.12 -0.03 0.01 0.05 0.14 0.01 0.00 51.37 51.37 0.00
z: Random - Regression -0.14 -0.02 0.02 0.07 0.17 0.02 0.00 57.06 57.06 0.00
d: Fixed - Copas -0.05 -0.01 0.00 0.01 0.11 0.01 19.38 56.41 37.03 56.92
d: Random - Copas -0.00 0.00 0.00 0.00 0.16 0.02 60.09 85.01 24.93 56.92
d: Fixed - Regression -0.21 -0.03 0.04 0.14 0.40 0.06 0.00 60.16 60.16 0.00
d: Random - Regression -0.20 -0.02 0.05 0.17 0.44 0.08 0.00 62.68 62.68 0.00
IV: Fixed - Copas -0.06 -0.01 0.00 0.01 0.07 0.00 23.97 42.15 66.12 59.50
IV: Random - Copas -0.00 0.00 0.00 0.01 0.08 0.01 61.98 28.93 90.91 59.50
IV: Fixed - Regression -0.24 -0.02 0.03 0.11 0.36 0.03 0.00 66.12 66.12 0.00
IV: Random - Regression -0.25 -0.02 0.04 0.13 0.49 0.05 0.00 68.59 68.59 0.00
Table 4.3: Quantiles and means of the differences between meta-analysis combined
treatment effects and small study adjusted treatment effects. The column with the
names “> 0” give the percentages of estimates larger than zero or larger or equal zero.
The column “No adj. est.” gives the percentage of missing estimates due to non-
significant publication bias test (for Copas) and computational errors. The row names
indicate which outcome measure, meta-analysis method and adjustment method is used.
Abbreviations are used for Fisher’s z-scores (z) and std. mean difference (d). Separate
rows give the results for IV outcomes, where the original effect sizes (log risk ratios, log
rate ratios, hazard ratios, etc.) are used.
id comparison.nr subgroup.nr z fixed z random z Copas z reg. d fixed d random d Copas d reg.
CD000370 8 2 0.80 0.81 0.80 0.97 1.59 1.59 1.40 0.28
CD001183 7 0 -0.54 -0.54 -0.54 -0.21 -1.10 -1.12 -0.50 -0.11
CD002307 2 1 -0.13 -0.11 -0.13 0.04 -0.47 -0.42 -0.41 -3.00
CD008625 2 2 -0.76 -0.72 -0.67 -0.48 -1.72 -2.02 -1.01 -0.69
CD010060 1 0 0.33 0.34 0.33 0.25 0.50 0.52 0.20 -0.49
Table 4.4: Missing meta-analysis combined treatment effect and adjusted treatment
effects. Abbreviations are used for Fisher’s z-scores (= z) and std. mean differences (=
d).
regression estimates have a little bit a larger absolute value. There might be some bias between
adjusted Fisher’s z-scores, where regression estimates seem to be somewhat smaller when the
mean is a little above zero, and somewhat larger when the mean is a little below zero.
4.2.3 Change in Evidence for Treatment Effects
Adjustment for small study effects in meta-analysis will provide new effect sizes and standard
errors. The evidence against the null hypothesis of no treatment effect can be computed newly.
The test statistics θse(θ) of random effects and fixed effects meta-analysis and the corresponding
adjusted test statistics are shown in Figure 4.10. The original scale of the effects sizes is used,
since it is the measure on which policy-makers assess the treatment efficacy.
The areas that are bordered by the diagonal and horizontal lines indicate which are the con-
sequences of adjustment for a dot within. “decrease” indicates fewer evidence for treatment effect
is given after adjustment, ”increase” that adjustment led to larger evidence for treatment effects.
It can be seen that the alignment on the diagonal changes depending on the adjustment method.
The effect of adjustment by Copas can be seen when comparing it to random effects meta-
analysis. There, less of an effect of adjustment on the evidence can be seen. The adjustment
is more likely to be more reliable than the unadjusted estimate when publication bias is strong
(see 2). The dots with darker color are thus more likely to provide less biased estimates.
The decrease in evidence is larger when using adjustment with regression, which can be expected
as the uncertainty of the additional parameter from the linear regression fit to estimate publica-
tion bias is included in the uncertainty of the estimate. In contrast, as the Copas selection model























95 % confidence intervals
Copas adjusted std. mean difference estimate − Regression adjusted std. mean difference estimate (original)
Figure 4.9: Mean - difference plots for publication bias adjustment methods. The
mean of the adjusted treatment effects is displayed on the x-axis and the difference on
the y-axis. Blue and red lines display the systematic error and the confidence intervals
of the systematic error (limits of agreement). Two values have been omitted in the
middle plot for std. mean difference and one for Fisher’s z-score (see Table 4.4).
algorithm does a sensitivity analysis, the uncertainty of additional model parameters does not
affect the estimate as they are not estimated but treated as fixed (see Section 3.3.3 and Section
2.6.2).
Large adjustment in effect sizes and test statistics is not necessarily accompanied by evidence
for publication bias (color of the dots) in regression adjustment, as already discussed. But the
dark dots can be found more often far away from the diagonal. Some cases which have more
evidence for treatment efficacy after adjustment have evidence for publication bias, although the
publication bias tests applied are one-sided and only test for bias towards large effects. This
is because the algorithm to detect the side on which publication bias was expected (Section
3.3.3) has failed, e. g . because few significant effects are given (used to define side of bias) and
the weighted mean effect is close to zero, in which case it is difficult to decide upon the side
of publication bias. There are some adjustments with large increase in evidence and clear dark
orange color, as in the plots on the right hand side in Figure 4.10. Two of them are investigated
in detail.
• z test statistic of regression adjustment 10.5 vs fixed effects z test statistic 5.7: When the
funnel plot of these meta-analyses are investigated, it becomes clear that there is no reason
to assume publication bias since the smaller studies are near to risk ratios equal to one, and
larger studies show larger ratios. Publication bias tests disagree in their findings (Rücker’s
and Harbord’s tests: 0.058 and 0.05, and Peters and Schwarzer’s test: 0.467 and 0.79).
• z test statistic of regression adjustment 9.24 vs fixed effects z test statistic 2.51: Asymme-
try of the funnel plot could be confirmed when analyzing it with mean differences. The
change to a larger treatment effect is rather due to large between study heterogeneity and
the specific routine of the regression adjustment. Because it takes into account between-
study heterogeneity (bias parameter times τ2), while fixed effects meta-analysis does not,
it returns a larger treatment effect. The adjusted effect (MD = - 10.3) lies between the
fixed effect estimate (-2.56) and the random effects estimate (-18.7).
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Figure 4.10: Test statistics of meta-analyses before and after adjustment. The color
indicates the evidence for publication bias (p-value of Rücker’s or Egger’s test), and
the dotted line depicts the diagonal through the origin. Together with the horizontal
dotted lines, the area which it borders indicates the consequences of adjustment for the
evidence for a treatment effect. “Decrease” means that the test statistic is smaller upon
adjustment, ”increase” that it is larger.
In the case of Copas selection model and when both test statistics are large (> 10), the explana-
tion lies in a specialty of the model; the adjusted treatment effect estimates are not larger than
the unadjusted, but their standard errors are different and sometimes smaller, because they are
obtained from the Fisher information matrix of the log-likelihood (see Subsection 2.6.2).
The Copas selection model also allows to compute the number of missing (i. e. unpublished) stud-
ies in a given meta-analysis, given that the model’s assumptions are correct. It finds that 2,618
are missing, which corresponds to 11.4% from all 22,916 analysed studies. Figure 4.11 shows
a histogram of the overall fraction of missing studies. Note that random effects meta-analysis
substitutes have been excluded (828 out of 1,388 to limit the size of the bin at no. missing studies
= 0.
We can see that in some occasions, the method finds more than half of all studies in a meta-
analysis are missing. In most occasions, the estimate of missing studies is zero, as can be seen in
Table 4.5, where both the absolute number of missing studies and the fraction of missing studies
in a meta-analysis are given. The discrepancy between mean and median may indicate that the
estimate of 11.4% missing studies depends somewhat on these extreme cases. As can be written
of from Table 4.5, 5%, i. e. 28 meta-analyses have 17.6 or more studies missing: in fact, these
5% most extreme make up for 1,060, more than 30% of all missing studies.












Figure 4.11: Histogram of the fraction of missing studies from the total number of
studies in a meta-analyses (only data shown where Copas estimate was obtained, thus
n = 560).
= 0 5% 25% 50% 75% 95% mean
Missing fraction 226 0 0 0.1 0.4 1.0 0.3
Missing study number 226 0 0 1.5 5.9 20.1 4.7
Table 4.5: Fraction of missing studies and estimates of missing studies with their zero
counts (“= 0”), quantiles and means.
4.3 Mixed Effects Models and Publication Bias over Time
To test if publication bias in meta-analyses has changed over time and newer meta-analyses have
less bias, a mixed linear model with random effects will be fitted (see Section 2.4). In terms of
(2.14), with random effects U , the formula is
yi|Uj , Uk, εi = xiβ + Uj + Uk + εi
where j and k are corresponding indexes for the meta-analysis and the review, and yi is the
effect size and xi the standard error belonging to result i. Additionally, weights equal to the
inverse of the standard errors are introduced. The framework allows to analyze all meta-analyses
jointly, such that statistical power is increased.
First, it is investigated if the model fit improves if we allow for random slopes within a meta-
analysis,. Then, we will introduce an interaction term between the year of review publication or
the mean study publication year and publication bias. If the interaction term improves model fit,
we will analyse the sign and the size of the interaction term, and otherwise state that no evidence
could be found that publication bias in meta-analyses changed over the years. Because it is a
exploratory analysis, the procedure is to first start with the simplest model and consecutively
add more explanatory variables and check by means of the AIC, BIC and F-test if the fit of the
model has improved. Fisher’s z-score are and its standard error is used for analysis. One model
will be fitted with review publication year and one with mean study publication year.
The dependent variable is the effect size z. As before in Section 4.2.1, the effect sizes are mirrored
to one side by multiplying with the sign of the expected side of bias, i. e. -1 or 1. Taking the
absolute values might obscure cases where the sign of the effect size changes but its absolute
value is equal.
In a first step, the explanatory variable is the standard error, and the weights are the inverse
of the variance of z. Additionally, random effects for the meta-analysis and for the review are
added, the former being nested in the latter. The details and evidence for the small study effects
in the mixed linear model are given in Table 4.6, the coefficients in Table 4.7:
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Model df AIC BIC logLik Test L.Ratio p-value
null.fit 1 4.0 1480.7 1512.6 -736.4
publication.bias.fit 2 5.0 1306.2 1346.1 -648.1 1 vs 2 176.5 <0.00001
Table 4.6: Anova table for a mixed linear model for small study effects compared to the
null model (’null.fit’). ’publication.bias.fit’ denotes the model with random intercepts
for meta-analyses and reviews.
estimate 2.5%CL 97.5%CL
(Intercept) 0.10 0.09 0.11
se.z.mirrored 0.52 0.44 0.59
Table 4.7: Coefficients and 95% confidence limits of the mixed linear model.
’se.z.mirrored’ denotes the standard error of the z-score.
It is possible to include meta-analysis specific random slopes. Before continuing, it is tested if
incorporation of random slopes improves model fit. Table 4.8 shows the anova table for a model
with and without random slopes. Model diagnostics indicate that there is no benefit in including
random slopes for the single meta-analysis.
To test if publication bias varies over time, we include the year of the publication of the review as
an additional explanatory variable. Ultimately, it is of interest if there is an interaction between
the small study effect (publication bias) and time of publication, i.e. if the slope varies depending
on the year. Because such a model is nested in a more simpler model where the study year is
only an additive effect, all these models are fitted. Table 4.9 displays model fit diagnostics.
Model df AIC BIC logLik Test L.Ratio p-value
publication.bias.fit 1 5.0 1306.2 1346.1 -648.1
publication.bias.rs.fit 2 7.0 1310.2 1366.0 -648.1 1 vs 2 0.0 1.0
Table 4.8: Anova table for two mixed linear model fits. ’publication.bias.fit’ denotes
the model with random intercepts for meta-analyses and reviews, ’publication.bias.rs.fit’
the model with additional random slopes per review.
Because neither AIC, BIC nor the F-test do show any improvement of model fit, we can not
reject the null hypothesis that publication bias has not decreased or increased over the years.
The review publication year is however only one measure of time, and possibly imprecise. Thus,
the models are re-fitted with the mean centered study publication year of a meta-analysis. The
mean of the study years is 2000.3.
The analysis of model fit in Table 4.10 indicates that there is no improvement when using
the study year as a covariate. Thus, there is no evidence for an interaction between small study
effects and mean study publication year.
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Model df AIC BIC logLik Test L.Ratio p-value
publication.bias.fit 1 5.0 1306.2 1346.1 -648.1
review.year.fit 2 6.0 1307.0 1354.8 -647.5 1 vs 2 1.2 0.27
review.year.int.fit 3 7.0 1308.4 1364.2 -647.2 2 vs 3 0.6 0.44
Table 4.9: Anova table for three mixed linear model fits. ’publication.bias.fit’ denotes
the model with the standard error as explanatory variable, ’review.year.fit’ the model
with standard error and the centered (- 2013) review year as explanatory variable, and
’review.year.int.fit’ the model with interaction between the two.
Model df AIC BIC logLik Test L.Ratio p-value
publication.bias.fit 1 5.0 1404.0 1443.8 -697.0
study.year.fit 2 6.0 1405.1 1452.8 -696.5 1 vs 2 0.9 0.334873
study.year.int.fit 3 7.0 1406.8 1462.6 -696.4 2 vs 3 0.2 0.639192
Table 4.10: Anova table for three mixed linear model fits. ’Small study fit’ denotes
the model with the standard error as explanatory variable, ’study.year.fit’ the model
with standard error and the centered (- 2000) mean study year of the meta-analysis
as explanatory variable, and ’study.year.int.fit’ the model with interaction between the
two.
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Chapter 5
Discussion
The aim of this study was to assess publication bias in the Cochrane Library, “the single, most
reliable source of evidence in healthcare” (citation from Cochrane). We applied a series of meth-
ods to test and adjust for publication bias in meta-analyses that matched our criteria.
The main result was that among the analysed meta-analyses, approximately 20% beared evi-
dence for publication bias. Adjustment for publication bias lead to a decrease in evidence for
treatment efficacy. After comparison with previous studies that analysed publication bias in the
Cochrane Library, we found that our results were similar to the results of these studies (e. g .
Egger et al., 1997, Ioannidis and Trikalinos, 2007a). A summary and comparison of this work to
most relevant research can be found in the appendix Chapter A.
Presence of publication bias in meta-analyses can ultimately lead to patient harm if decision mak-
ers in clinical practice use the meta-analyses to decide about application of a treatment. Publica-
tion bias does in general lead to exaggerated confidence in the results of the meta-analyses. It is
possible that the evidence for a treatment in a meta-analysis is merely an artifact of publication
bias. This also leads to a waste of resources in science.
The fact that Cochrane also uses study reports from Grey literature and other unpublished
data (1.5% of the analysed data), which contain usually smaller effect sizes, likely mitigates our
estimate of publication bias.
5.1 Limitations
This is an exploratory study, and the results are rather suggestive than confirmatory. As a part
of evidence it is supposed to strengthen previous assessments of publication bias and possibly,
guide further research.
It is clear that publication bias could only be assessed in a part of all meta-analyses of the
Cochrane Library and that the extent of publication bias in the remaining data is unknown.
Because one inclusion criterion was that more than ten study results had to be available for a
given research question, the analysed dataset contains rather the part of data with established
and enduring research. When research is more experimental and exploratory, it may well be that
publication bias is an issue as well, or even more of an issue. Publication bias is possibly related
to more discovery oriented, modern research (Ioannidis, 2005).
There is an unknown amount of meta-analyses with secondary outcomes in the analysis. It is
not well investigated if and how secondary outcomes are affected by publication bias, and how
much they are affected by between-study heterogeneity, as researchers might not follow common
protocols as rigidly when assessing secondary outcomes. Together with unremoved adverse effect
meta-analyses, which are likely subject to different kinds of publication bias, they can distort or
mitigate the estimated extent of publication bias in this study. If one assumes that publication
bias is not as strong in secondary outcomes as in primary outcomes, and that adverse effects are
subject to bias for small effects (as suggested by Kicinski et al., 2015), the extent of publication
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bias will be underestimated.
Some criticism can be addressed on the methods. The small study effect which is used as an
indication for publication bias can be caused by other biases such as selective outcome reporting,
data fabrication, poor methodological quality of smaller studies or delayed publication of non-
significant results. It can also be caused by true heterogeneity between studies; early and small
studies are more likely to include high-risk patients for which treatment can have larger benefits.
However, true heterogeneity between smaller and larger studies might as well mask the presence
of publication bias, for example if smaller studies have smaller effects due to true between-study
heterogeneity. Where effect size estimates and their standard errors are not independent (e. g . log
risk ratios and std. mean differences), small study effect can be a statistical artifact. However,
methods to avoid this issue have largely been applied.
Also, small study effect tests do not use statistical significance directly. They will fail when there
are no significant results, but the smaller studies have larger effects than the larger studies, in
which case no publication bias for significant results could exist. The only test that is applied
that takes into account statistical significance per se is the excess significance test, which is
underpowered. Therefore, we restricted the meta-analyses such that at least one significant
effect had to be included.
Most small study effect tests rely on linear regression. Linear regression is prone to outliers,
especially if the sample size is small. The issue is partially resolved by weighting, but the usual
procedure to assess if the model assumptions are fulfilled is not applicable for such a large number
of model fits.
All the criticism also applies for adjustment methods, as they also rely on small study effects. A
weakness of the regression adjustment is that it also adjusts if the uncertainty in the small study
effect is large. To compare it in this case with the meta-analysis estimate is difficult because
the uncertainty in estimating the small study effect is added to the uncertainty of the treatment
effect, which inflates the uncertainity of the adjusted treatment effect.
Copas selection model uses the p-value threshold of 0.1 to decide if adjustment is necessary or
not. One could argue that this threshold is somewhat arbitrary. Another issue that the model is
not estimating the selection process parameters, but rather applying some criteria of parsimony
(the model that assumes fewest publication bias with p-value for small study effect > 0.1 is
chosen).
Both models use various assumptions that likely affect the results. But in simulations, the
methods all had fewer mean-squared error and bias than the classical meta-analysis methods
when publication bias was present.
Publication bias can also be present if a meta-analysis lacks a small study effect, for example if
significant results are published irrespective of the sign of the effect estimate. Methods as the
excess significance test of Ioannidis and Trikalinos (2007b) are applied to overcome this issue,
but the method is known to lack power. No methods exist so far to adjust for excess significance.
This could lead to underestimated.
Given the large body of evidence for publication bias by other means, it is unlikely that the
unexpectedly large proportion of significant test results and the downward corrected treatment
effect estimates are merely false positives or caused by other biases. Of course, the general
practice is to apply all the methods in this study carefully, and with background knowledge
about each single study in the meta-analyses, to differentiate between true heterogeneity and
publication bias. But this does not disqualify these results, but stress the necessity that authors
of meta-analyses investigate possible publication bias thoroughly.
5.1.1 A Note on the Use of Effect Size Measures
An inevitable issue for the analysis of publication bias and adjustment for it is the choice of the
effect size measure. Researchers and journal editors rely on effect sizes as mean differences or log
odds ratios to assess treatment efficacy and statistical significance. Transformation of the effect
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sizes might change a significant result to non-significant or vice-versa. Thus, transformation will
lead to a loss of accuracy. Furthermore, transformation of mean differences to std. mean differ-
ences also comes with the unpleasant consequence that the estimates of effect size and std. mean
difference are no longer independent (as for mean differences, where the effect size and standard
error is not mathematically linked). This will lead to false positives. When transforming odds
ratios to std. mean differences, the dependence between the estimated log odds ratio and std.
error is also retained, again leading to false positives. See Deeks et al. (2005) for a thorough
discussion of correlation between effect sizes and standard errors in publication bias tests. Using
Fisher’s z-score is more appropriate since standard errors and effect sizes are independent.
5.2 Outlook
It would be possible to further narrow the subset of meta-analyses where publication bias is
likely. For example, one could choose meta-analyses with large proportions of significant results.
Treatment effect adjustment and consequences of adjustment for evidence for treatment effect
could subsequently be analysed more carefully. Related to this, implementation of a likelihood
ratio test in Copas selection model, as proposed by the authors, would be feasible and increase
accuracy.
Many researchers have come up with hypotheses about the reasons and circumstances that pro-
mote publication bias, which could be tested if the dataset is extended. Meta meta-regression as
introduced in the last chapter might be a suitable way to test these hypotheses in an exploratory
manner.
There are numerous suggestions for different measures of publication bias and small study effects,
which could be applied on the dataset (see Mueller et al., 2016). This study mainly relies on
suggestions from Sterne et al. (2001), Ioannidis and Trikalinos (2007a) and Rücker et al. (2011).
It uses most often methods that are well integrated in packages (Viechtbauer, 2010, Schwarzer,
2007). Although there are well addressed, mathematical justifications for these methods, there
might be better methods not yet tested on large datasets. An evaluation of all suggested methods
was unfortunately beyond the scope of this study.
5.3 Implications
As far as we know, this study is so far one of the largest assessment of publication bias by small
study effects and uses also data that has been collected after major efforts have been made to
curb publication bias. Furthermore, the analysis includes time-to-event data which is, as far
as we are aware of, unprecedented, and continuous outcomes, which are often not considered.
Thus, we assume that it is so far the most complete, thorough analysis of publication bias in the
Cochrane library.
We are not aware of any use of one-sided tests for publication bias as used in this study, which al-
lows to look more specifically for publication bias for significant, “positive” or “desired” treatment
effects in a large scale. We find a proportion of significant test results well above the expected
false positive rate of the tests of 10%.
Also, it is among the first study to extensively adjust the combined effect sizes from meta-
analyses for publication bias. It has been found repeatedly that publication bias might threaten
the validity of the findings of some meta-analyses from Cochrane systematic reviews. Cochrane
did so far not extend their protocols to publication bias adjustment methods.
Therefore, we suggest that publication bias in meta-analyses of clinical trials remains an impor-
tant issue to be considered while doing meta-analyses.
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Appendix A
Appendix
A.1 Comparison of Results with Previous Studies
For the interested reader, some results of similar studies are discussed briefly and compared to
the results of this study, if possible. When clear methodological drawbacks are found in the
analysis, the reader is referred to chapter 2 for comments on the disadvantages. The amount of
studies analyzing publication bias makes it not possible to discuss each of them, and thus only
some interesting and/or representative examples are shown.
A.1.1 Egger et al., 1997
The Cochrane Library (1996 issue 2) and publications from the four leading medicine journals
(the Lancet, BMJ, JAMA and Annals of Internal Medicine) between 1993 and 1996 were used
to find systematic reviews with randomized controlled trials for the application of Egger’s small
study effect test. They included 38 meta-analyses with at least 5 studies and binary outcomes
from the Cochrane Library and 37 from the journals. Five (13%) meta-analyses from Cochrane
and 13 (38%) from the journals had significant two sided small study effect test results (p-value
< 0.1). Also, they found that test-statistics were more often negative, which corresponded in
their setup to larger effects in small studies. (63.2 among Cochrane meta-analyses and 70.3 for
journal meta-analyses). The results from this report with Rücker’s test are: 14.8%, and when
using regression adjustment to decide about the direction of publication bias, we get 80.7%.
A.1.2 Sutton et al., 2000
Out of 397 systematic reviews from the Cochrane Library (complete number for 1998, issue 3),
49 had more than ten included studies and binary outcomes and 48 compared two treatments.
They were analysed by trim-and-fill method (Duval and Tweedie, 2000) to detect and adjust
for funnel plot asymmetry (similar to small study effect tests, but the method is known to
overestimate bias). 23 were found to have missing studies, and eight had more than three
missing studies which was considered to be significant publication bias. Additionally, they found
that three estimates of random effects meta-analysis became non-significant after adjustment,
and one became significant (by negative adjustment). The results are difficult to compare, but
the methodological limitations make this findings unreliable.
A.1.3 Ioannidis and Trikalinos, 2007a
Data processing steps were however different, and only binary outcomes as used in two-by-two
tables were analysed. The approximately corresponding numbers are put in parentheses for
comparison. The Cochrane Library from 2003 (issue 2) was used. After removal of duplicates
and intractable meta-analyses, they had 6,873 meta-analyses with more than two studies left
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(20,219). When only using one meta-analysis per review, this reduced to 846 (3,555. Then, the
criteria that have also been applied in this masters study are applied: I2 < 0.5, variance ratio of
smallest and largest effects > 4, at least one significant study result and at least 10 studies to be
used. Afterwards, they applied Harbord’s, Egger’s and Begg’s Test to the dataset. The reader
can compare some corresponding numbers in Table A.1.
Ioannidis Study
Wider dataset (n) 6873 20219
study number > 10 13% 12%
variance ratio > 4 72% 75%
study sig. number > 1 55% 52%
all exclusion criteria 5% 5%
Harbord test p-value < 0.1 12% 16%
Table A.1: Comparison of results from Ioannidis et.al. (2007) to the results of this
study. The percentage of meta-analysis which match all exclusion criteria denotes
the ones that apply to all criteria in the table plus the small heterogeneity criterium.
Harbord test is two-sided.
A.1.4 Souza et al., 2007
Reviews of the World Health Organization (WHO) Reproductive Health Library (RHL), issue
9, were analysed with the trim-and-fill method. The RHL reproduces and expands reviews from
the Cochrane Library with implications for developing countries. 21 of 105 reviews contained
more than ten studies and were used. Trim-and-fill found asymmetry in 18 of 21 studies, and
10 had more than 3 missing studies (“significance”). Two of those and one with one missing
studies found no evidence for treatment effects after the 0.05 p-value threshold after adjustment
by trim-and-fill.
A.1.5 Kicinski et al., 2015
The author uses a Bayesian hierarchical selection model, but does not analyse treatment effects,
but the parameters of the weight function of the selection model, which is estimated with a
Bayesian approach and MCMC sampling.
The author provides an estimate of the probability of including significant findings versus non-
significant findings in Cochrane meta-analyses over time. The data is from the Cochrane Library
from 2013 (issue number not provided). The author excluded treatment - treatment compar-
isons and analysed safety and efficacy meta-analyses separately (how this was achieved is not
documented in the paper).
From 3845 reviews, the author separated 907 reviews with more than ten studies. From those,
539 compared placebo to treatment. After removing duplicates and sensitivity analyses, 358
analyses with 1297 meta-analyses remained. From these 191 were excluded because they com-
prised overall mortality and withdrawal, because these could not clearly be specified as safety or
efficacy, respectively.
1106 meta-analyses from 329 meta-analyses, containing 802 efficacy and 304 safety meta-analyses.
The median publication year per meta-analysis was 1997 for efficacy meta-analyses and 1999 for
safety meta-analyses. Then, a Bayesian two-step hierarchical selection model was applied (Kicin-
ski, 2013, Silliman, 1997). It assumes that the selection process is a two-step weight function,
which assigns different probabilities to non-significant and significant effects. Thus, a ratio of
publication probability between significant and non-significant study estimates using a two-step
weight function. The model was fitted with the Monte-Carlo Markov-Chain algorithm STAN and
the geometric mean was used as an estimate for the publication probability ratio. Simulations
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performed in (Kicinski, 2013) indicate that the method performs well if the true mean effect size
was not small, and also robust to small study effects. It outperformed Egger’s test and Begg’s
test in assessing publication bias, especially when small study effects were absent, and had lower
false-positive rates.
The results showed a clear publication bias for significant results for efficacy meta-analyses (27%
higher for significant studies, 95%CI credible intervals: 1.18 to 1.36). The probability was more
than twice as high in 27% of the meta-analyses (95% CI: 23% to 31%). But the probability
decreased: from 1.65 (95% CI: 1.31 to 2.15) in 1980 (average publication year) to 1.36 (95%
CI: 1.17 to 1.62) in 1990 to 1.18 (95% CI: 1.04 to 1.33) in 2000. For sake of completeness, the
probability of inclusion was 1.78 (95% CI: 1.51 to 2.13) larger for non-significant safety effect
estimates, but again, decreased with time (1.77, 95% CI: 1.46 to 2.21 in 2000). The results are
in line with the results from this study, but it was not possible to reaffirm the finding of weaker
publication bias in reviews published more frequently.
A.1.6 van Aert et al., 2019
The Authors of this recent study sample 366 meta-analyses randomly from the Cochrane Li-
brary (supposedly 2018 or 2019, not mentioned). They exclude any meta-analysis which include
effect sizes identical to effect sizes in other meta-analyses (the larger meta-analysis is retained).
Additional criteria were: I2 < 0.5 and at least 5 studies. The meta-analyses were analysed
using standardized mean differences and four different tests for publication bias: Egger’s test,
p-uniform test (Van Assen et al., 2015), Begg and Mazumdar’s rank correlation test and the
excess significance test.
The authors found, based on the significance threshold of p < 0.1, the following results (own
results in brackets): 12.2 % significant results from Egger’s test (16.3), 8.5 % significant results
from Begg and Mazumdar’s rank correlation test (10.5) and 4.4 % significant excess significance
test results (9.7). It is known that the publication bias tests are lacking power in general as
sample size is usually small. Decreasing sample size will result in lower power, especially if the
maximal sample size is n ≥ 5. Additionally, it was also not taken into consideration that it may
be difficult to state that publication bias is present in a meta-analysis when no result within it
is statistically significant (only 18.8 % of the effects of the sampled meta-analyses were). This,
together that it has not been tried to exclude safety outcomes, may account for the large differ-
ences between the results.
The author’s come to the conclusion in their study that in contrast to other studies, they find
few evidence for publication bias.
A.1.7 Further Studies on Publication Bias
Zhang et al., 2013 find publication bias in critical care studies with similar methods. Nüesch
et al., 2010 report publication bias in clinical osteoarthritis research because of funnel plot asym-
metry and pledge for routine assessment of publication bias. Dechartres et al., 2013 analyse
publication bias based on sample size in meta-analyses from top journals and Cochrane reviews
in 93 Meta-analyses and find that, for example, effects in trials with less than 50 patients were
48% larger than in larger trials. Onishi and Furukawa, 2014 find that in 36 Meta-Analyses with-
out comprehensive literature research, there are 19.4% significant publication bias tests (Egger’s
test).
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sessionInfo()
## R version 3.5.1 (2018-07-02)
## Platform: x86_64-apple-darwin15.6.0 (64-bit)
## Running under: macOS 10.14.5
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## attached base packages:
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##
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## [22] labeling_0.3 munsell_0.5.0 broom_0.5.0
## [25] compiler_3.5.1 modelr_0.1.2 pkgconfig_2.0.2
## [28] tidyselect_0.2.5 seriation_1.2-7 codetools_0.2-15
## [31] dendextend_1.12.0 viridisLite_0.3.0 crayon_1.3.4
## [34] withr_2.1.2 bitops_1.0-6 MASS_7.3-51.1
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